Guidelines for endoscopic and robotic breast surgery in China (2026 edition): Part two_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

 DU Zhenggui ¹ ,  Lü Qing ¹ , Lü Pengwei ² , SONG Dajiang ³ , WANG Zihan ⁴ , YANG Benlong ⁵ , SU Shicheng ⁶ , on behalf of the Chinese Endoscopic-robotic Breast Surgery Clinical Trials Consortium (CErBSCTC)

1. Breast Disease Center of West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
2. Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China;
3. Department of Oncologic Plastic Surgery, Hunan Cancer Hospital, Changsha, 410013, P. R. China;
4. Department of Breast Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing, 100020, P. R. China;
5. Breast Surgery Department, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China;
6. Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China;

Corresponding?author：

DU Zhenggui, Email: docduzg@163.com; Lü Qing, Email: lqlq1963@163.com

Keywords：

Breast cancer; endoscopic surgery; robotic surgery; breast reconstruction; perioperative management; surgical standardization; breast disease prevention and control; guidelines

DOI：

10.7507/1007-4848.202602008

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

This guideline, presented in three parts, details the core aspects of endoscopic/robotic breast surgery, including its techniques, equipment, surgical procedures, perioperative management, complication treatment, long-term follow-up, and outcomes. Part one offered a comprehensive overview of indications for endoscopic and robotic breast surgery, intraoperative techniques, surgical instrument choices, and common endoscopic and robotic breast reconstruction procedures. This part will cover other endoscopic breast procedures beyond immediate breast reconstruction and include perioperative management strategies, to provide healthcare professionals involved in endoscopic and robotic breast surgery with systematic operational guidelines and clinical decision-making references.

Citation： DU Zhenggui, Lü Qing, Lü Pengwei, SONG Dajiang, WANG Zihan, YANG Benlong, SU Shicheng, on behalf of the Chinese Endoscopic-robotic Breast Surgery Clinical Trials Consortium (CErBSCTC). Guidelines for endoscopic and robotic breast surgery in China (2026 edition): Part two. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2026, 33(4): 487-521. doi: 10.7507/1007-4848.202602008 Copy

1.	杜正貴, 呂青, 呂鵬威, 等. 中國腔鏡/機器人乳腺手術指南 (2026版): 第一部分. 中國胸心血管外科臨床雜志, 2026, 33(2): 167-203.Du ZG, Lü Q, Lü PW, et al. Guidelines for endoscopic and robotic breast surgery in China (2026 edition): part one. Chin J Clin Thorac Cardiovasc Surg, 2026, 33(2): 167-203.
2.	杜正貴, 呂青, 呂鵬威. 中國腔鏡/機器人乳腺手術指南(2026版) 計劃書. 中國胸心血管外科臨床雜志, 2026, 33(3): 333-338.Du ZG, Lü Q, Lü PW, et al. Protocol for China endoscopic and robotic breast surgery guidelines (2026 edition). Chin J Clin Thorac Cardiovasc Surg, 2026, 33(3): 333-338.
3.	Li X, You R, Wang X, et al. Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review. Clin Cancer Res, 2016, 22(15): 3971-3981.
4.	Young MO. Prophylactic simple mastectomy. Rocky Mt Med J, 1966, 63(5): 31-32.
5.	Lynch HT, Shaw MW, Magnuson CW, et al. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med, 1966, 117(2): 206-212.
6.	Fayanju OM, Stoll CR, Fowler S, et al. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg, 2014, 260(6): 1000-1010.
7.	Srethbhakdi A, Brennan ME, Hamid G, et al. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: systematic review of patient reported outcomes. Psychooncology, 2020, 29(6): 960-973.
8.	King MC. "The race" to clone BRCA1. Science, 2014, 343(6178): 1462-1465.
9.	Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature, 1995, 378(6559): 789-792.
10.	Mavaddat N, Peock S, Frost D, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst, 2013, 105(11): 812-822.
11.	Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 2017, 317(23): 2402-2416.
12.	Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med, 2001, 345(3): 159-164.
13.	Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol, 2004, 22(6): 1055-1062.
14.	Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, 2010, 304(9): 967-975.
15.	Blondeaux E, Sonnenblick A, Agostinetto E, et al. Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study. Lancet Oncol, 2025, 26(6): 759-770.
16.	Carlson RW, Brown E, Burstein HJ, et al. NCCN Task Force report: adjuvant therapy for breast cancer. J Natl Compr Canc Netw, 2006, 4 (Suppl 1): S1-26.
17.	Balma?a J, Díez O, Rubio IT, et al. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol, 2011, 22(Suppl 6): vi31-vi34.
18.	Robson ME, Bradbury AR, Arun B, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol, 2015, 33(31): 3660-3667.
19.	McGuire KP, Mamounas EP. Management of hereditary breast cancer: ASCO, ASTRO, and SSO guideline. Ann Surg Oncol, 2020, 27(6): 1721-1723.
20.	中國臨床腫瘤學會乳腺癌專家委員會, 中國抗癌協會乳腺癌專業委員會, 中華醫學會外科學分會乳腺外科學組. 中國年輕乳腺癌診療專家共識 (2022). 中華醫學雜志, 2023, 103(6): 387-403.Chinese Society of Clinical Oncology, Experts Committee on Breast Cancer; China Anti-Cancer Association, the Society of Breast Cancer; Chinese Medical Association, Chinese Society of Breast Surgery. Expert consensus on the diagnosis and treatment of young breast cancer in China (2022 edition). Natl Med J China, 2023, 103(6): 387-403.
21.	中國醫師協會精準治療委員會乳腺癌專業委員會, 中華醫學會腫瘤學分會乳腺腫瘤學組, 中國抗癌協會乳腺癌專業委員會, 等. 中國乳腺癌患者BRCA1/2基因檢測與臨床應用專家共識(2018年版). 中國癌癥雜志, 2018, 28(10): 787-800.Breast Cancer Professional Committee, Precision Treatment Committee of Chinese Medical Doctor Association; Breast Oncology Group, Society of Oncology, Chinese Medical Association; China Anti-Cancer Association, the Society of Breast Cancer, et al. Chinese expert consensus on BRCA1/2 gene detection and clinical application in breast cancer patients (2018 edition). China Oncol, 2018, 28(10): 787-800.
22.	Kratz CP, Achatz MI, Brugières L, et al. Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res, 2017, 23(11): e38-e45.
23.	Lynch HT, Watson P, Conway TA, et al. Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat, 1990, 15(2): 63-71.
24.	Barnes DR, Silvestri V, Leslie G, et al. Breast and prostate cancer risks for male BRCA1 and BRCA2 pathogenic variant carriers using polygenic risk scores. J Natl Cancer Inst, 2022, 114(1): 109-122.
25.	Pashayan N, Pharoah PD, Schleutker J, et al. Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. Br J Cancer, 2015, 113(7): 1086-1093.
26.	Seibert TM, Fan CC, Wang Y, et al. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. BMJ, 2018, 360: j5757.
27.	Kurian AW, Hare EE, Mills MA, et al. Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol, 2014, 32(19): 2001-2009.
28.	Lakeman IMM, Rodríguez-Girondo MDM, Lee A, et al. Clinical applicability of the polygenic risk score for breast cancer risk prediction in familial cases. J Med Genet, 2023, 60(4): 327-336.
29.	Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene, 2008, 27(41): 5387-5397.
30.	Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns, 2009, 18(1): 13-27.
31.	Mester J, Charis E. PTEN hamartoma tumor syndrome. Handb Clin Neurol, 2015, 132: 129-37.
32.	Pilarski R, Stephens JA, Noss R, et al. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet, 2011, 48(8): 505-512.
33.	Varga EA, Pastore M, Prior T, et al. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med, 2009, 11(2): 111-117.
34.	Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, et al. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome. J Natl Cancer Inst, 2023, 115(1): 93-103.
35.	Roberts ME, Ranola JMO, Marshall ML, et al. Comparison of CDH1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers. JAMA Oncol, 2019, 5(9): 1325-1331.
36.	Ryan CE, Fasaye GA, Gallanis AF, et al. Germline CDH1 variants and lifetime cancer risk. JAMA, 2024, 332(9): 722-729.
37.	Breast Cancer Association Consortium, Mavaddat N, Dorling L, et al. Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes. JAMA Oncol, 2022, 8(3): e216744.
38.	Breast Cancer Association Consortium, Dorling L, Carvalho S, et al. Breast cancer risk genes: association analysis in more than113, 000 women. N Engl J Med, 2021, 384(5): 428-439.
39.	Yang X, Leslie G, Doroszuk A, et al. Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol, 2020, 38(7): 674-685.
40.	Marabelli M, Cheng SC, Parmigiani G. Penetrance of ATM gene mutations in breast cancer: a meta-analysis of different measures of risk. Genet Epidemiol, 2016, 40(5): 425-431.
41.	Hearle N, Schumacher V, Menko FH, et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res, 2006, 12(10): 3209-3215.
42.	Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med, 1999, 340(2): 77-84.
43.	Reiner AS, John EM, Brooks JD, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol, 2013, 31(4): 433-439.
44.	Gradishar WJ, Anderson BO, Abraham J, et al. Breast cancer, version 3. 2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2020, 18(4): 452-478.
45.	中華醫學會外科學分會乳腺外科學組. 中國家族遺傳性乳腺癌行預防性乳房切除術臨床實踐指南(2024版). 中國實用外科雜志, 2024, 44(11): 1201-1205.Chinese Society of Breast Surgery, Chinese Society of Surgery, Chinese Medical Association. Guideline on the clinical practice for prophylactic mastectomy in hereditary breast cancer in China (2024 edition). Chin J Pract Surg, 2024, 44(11): 1201-1205.
46.	Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA, 2003, 290(4): 465-475.
47.	Henderson TO, Amsterdam A, Bhatia S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med, 2010, 152(7): 444-455.
48.	National Comprehensive Cancer Network. Cancer-related fatigue. Clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2003, 1(3): 308-331.
49.	Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2019, 30(8): 1194-1220.
50.	Hoogerbrugge N, Bult P, de Widt-Levert LM, et al. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol, 2003, 21(1): 41-45.
51.	Chuba PJ, Hamre MR, Yap J, et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol, 2005, 23(24): 5534-5541.
52.	King TA, Pilewskie M, Muhsen S, et al. Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol, 2015, 33(33): 3945-3952.
53.	王濤, 江澤飛. 乳腺癌輔助治療若干問題的思考和討論—2008年《NCCN乳腺癌臨床實踐指南中國版》解讀. 臨床腫瘤學雜志, 2008, 13(9): 846-848.Wang T, Jiang ZF. Considerations and discussion on key issues in adjuvant breast cancer therapy: an interpretation of the 2008 NCCN breast cancer clinical practice guidelines (Chinese edition). Chin Clin Oncol, 2008, 13(9): 846-848.
54.	Gradishar W J, Moran M S, Abraham J, et al. NCCN Guidelines insights: breast cancer, version 5. 2025. J Natl Compr Canc Netw, 2025, 23(11): 426-436.
55.	中國抗癌協會乳腺癌專業委員會, 中華醫學會腫瘤學分會乳腺腫瘤學組. 中國抗癌協會乳腺癌診治指南與規范 (2024年版). 中國癌癥雜志, 2023, 33(12): 1092-1187.China Anti-Cancer Association, the Society of Breast Cancer; Breast Oncology Group of the Oncology Branch of the Chinese Medical Association. Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition). China Oncol, 2023, 33(12): 1092-1187.
56.	Karabeg R, Jakirlic M, Karabeg A, et al. The new method of pocket forming for breast implant placement in augmentation mammaplasty: dual plane subfascial. Med Arch, 2019, 73(3): 178-182.
57.	Zhou J, Xie Y, Liang F, et al. A novel technique of reverse-sequence endoscopic nipple-sparing mastectomy with direct-to-implant breast reconstruction: medium-term oncological safety outcomes and feasibility of 24-h discharge for breast cancer patients. Int J Surg, 2024, 110(4): 2243-2252.
58.	Lee DW, Kim SJ, Kim H. Endoscopic transaxillary versus inframammary approaches for breast augmentation using shaped implants: a matched case-control study. Aesthetic Plast Surg, 2019, 43(3): 563-568.
59.	Kolker AR, Austen WG, Slavin SA. Endoscopic-assisted transaxillary breast augmentation: minimizing complications and maximizing results with improvements in patient selection and technique. Ann Plast Surg, 2010, 64(5): 667-673.
60.	Stevens WG, Stoker DA, Freeman ME, et al. Is one-stage breast augmentation with mastopexy safe and effective? A review of 186 primary cases. Aesthet Surg J, 2006, 26(6): 674-681.
61.	Razdan SN, Panchal H, Albornoz CR, et al. Impact of contralateral symmetry procedures on long-term patient-reported outcomes following unilateral prosthetic breast reconstruction. J Reconstr Microsurg, 2019, 35(2): 124-128.
62.	Churchill IF, Gallo L, Dunn E, et al. Complications and burden of 2-stage tissue expander to implant-based reconstructive surgery: a single-center retrospective study. Plast Surg (Oakv), 2025, 33(2): 201-207.
63.	Daar DA, Abdou SA, Rosario L, et al. Is there a preferred incision location for nipple-sparing mastectomy? A systematic review and meta-analysis. Plast Reconstr Surg, 2019, 143(5): 906e-919e.
64.	Feng Y, Xie Y, Liang F, et al. Twenty-four-hour discharge of patients after endoscopic nipple-sparing mastectomy and direct-to-implant breast reconstruction: safety and aesthetic outcomes from a prospective cohort study. Br J Surg, 2024, 111(1): znad356.
65.	Harvey KL, Sinai P, Mills N, et al. Short-term safety outcomes of mastectomy and immediate prepectoral implant-based breast reconstruction: pre-BRA prospective multicentre cohort study. Br J Surg, 2022, 109(6): 530-538.
66.	Heimes AS, Stewen K, Hasenburg A. Psychosocial aspects of immediate versus delayed breast reconstruction. Breast Care (Basel), 2017, 12(6): 374-377.
67.	Qiu M, Yang H, Zhou J, et al. Short-term safety and cosmetic outcomes of endoscopic direct-to-implant breast reconstruction and simultaneous contralateral breast augmentation for breast cancer: a prospective analysis of 33 patients. World J Surg Oncol, 2023, 21(1): 201.
68.	Tebbetts JB. Dual plane breast augmentation: optimizing implant-soft-tissue relationships in a wide range of breast types. Plast Reconstr Surg, 2006, 118(7 Suppl): 81S-102S.
69.	Tebbetts JB. Dual plane breast augmentation: optimizing implant-soft-tissue relationships in a wide range of breast types. Plast Reconstr Surg, 2001, 107(5): 1255-1272.
70.	Tebbetts JB. Axillary endoscopic breast augmentation: processes derived from a 28-year experience to optimize outcomes. Plast Reconstr Surg, 2006, 118(7 Suppl): 53S-80S.
71.	Graf RM, Bernardes A, Rippel R, et al. Subfascial breast implant: a new procedure. Plast Reconstr Surg, 2003, 111(2): 904-908.
72.	Brown T. A comprehensive outcome review of subfascial breast augmentation over a 10-year period. Plast Reconstr Surg, 2020, 146(6): 1249-1257.
73.	Gould DJ, Shauly O, Ohanissian L, et al. Subfascial breast augmentation: a systematic review and meta-analysis of capsular contracture. Aesthet Surg J Open Forum, 2020, 2(1): ojaa006.
74.	von Sperling ML, H?imyr H, Finnerup K, et al. Persistent pain and sensory changes following cosmetic breast augmentation. Eur J Pain, 2011, 15(3): 328-332.
75.	Tan P, Martin MS, Shank N, et al. A comparison of 4 analgesic regimens for acute postoperative pain control in breast augmentation patients. Ann Plast Surg, 2017, 78(6 Suppl 5): S299-S304.
76.	Govrin-Yehudain O, Matanis Y, Govrin-Yehudain J. Reduced pain and accelerated recovery following primary breast augmentation with lightweight breast implants. Aesthet Surg J, 2018, 38(10): 1092-1096.
77.	Kang CM, Kim WJ, Yoon SH, et al. Postoperative pain control by intercostal nerve block after augmentation mammoplasty. Aesthetic Plast Surg, 2017, 41(5): 1031-1036.
78.	Fredman R, Wu C, Rapolti M, et al. Prepectoral direct-to-implant breast reconstruction: early outcomes and analysis of postoperative pain. Aesthet Surg J Open Forum, 2019, 1(1): ojz006.
79.	Ciftci B, Ekinci M, Celik EC, et al. Ultrasound-guided pectoral nerve block for pain control after breast augmentation: a randomized clinical study. Braz J Anesthesiol, 2021, 71(1): 44-49.
80.	Sforza M, Saghir R, Saghir N, et al. Assessing the efficacy of the S-PECS block in breast augmentation surgery: a randomized, double-blind, controlled trial. Plast Reconstr Surg, 2024, 153(1): 1e-9e.
81.	Graf RM, Bernardes A, Auersvald A, et al. Subfascial endoscopic transaxillary augmentation mammaplasty. Aesthetic Plast Surg, 2000, 24(3): 216-220.
82.	Pereira LH, Sterodimas A. Transaxillary breast augmentation: a prospective comparison of subglandular, subfascial, and submuscular implant insertion. Aesthetic Plast Surg, 2009, 33(5): 752-759.
83.	Aygit AC, Basaran K, Mercan ES. Transaxillary totally subfascial breast augmentation with anatomical breast implants: review of 27 cases. Plast Reconstr Surg, 2013, 131(5): 1149-1156.
84.	Sim HB. Revisiting prepectoral breast augmentation: indications and refinements. Aesthet Surg J, 2019, 39(5): NP113-NP122.
85.	Yuan M, Kim P, Gallo L, et al. Outcomes in subfascial versus subglandular planes in breast augmentation: a systematic review and meta-analysis. Aesthet Surg J, 2024, 44(9): NP639-NP644.
86.	Shen Z, Chen X, Sun J, et al. A comparative assessment of three planes of implant placement in breast augmentation: a bayesian analysis. J Plast Reconstr Aesthet Surg, 2019, 72(12): 1986-1995.
87.	Sim HB. Transaxillary endoscopic breast augmentation. Arch Plast Surg, 2014, 41(5): 458-465.
88.	Lista F, Ahmad J. Evidence-based medicine: augmentation mammaplasty. Plast Reconstr Surg, 2013, 132(6): 1684-1696.
89.	Schwartz MR. Evidence-based medicine: breast augmentation. Plast Reconstr Surg, 2017, 140(1): 109e-119e.
90.	Wong CH, Samuel M, Tan BK, et al. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg, 2006, 118(5): 1224-1236.
91.	Ostapenko E, Nixdorf L, Devyatko Y, et al. Prepectoral versus subpectoral implant-based breast reconstruction: a systemic review and meta-analysis. Ann Surg Oncol, 2023, 30(1): 126-136.
92.	Benito-Ruiz J, Manzano ML, Salvador-Miranda L. Five-year outcomes of breast augmentation with form-stable implants: periareolar vs transaxillary. Aesthet Surg J, 2017, 37(1): 46-56.
93.	Shi H, Cao C, Li X, et al. A retrospective study of primary breast augmentation: recovery period, complications and patient satisfaction. Int J Clin Exp Med, 2015, 8(10): 18737-18743.
94.	Bak K, Cameron EA, Henderson IJ. Rupture of the pectoralis major: a meta-analysis of 112 cases. Knee Surg Sports Traumatol Arthrosc, 2000, 8(2): 113-119.
95.	Li L, Liang Y, Li C, et al. Comparison of endoscopic breast-conserving surgery versus conventional breast-conserving surgery for the treatment of early-stage breast cancer: a meta-analysis. Front Oncol, 2024, 14: 1419123.
96.	Lai HW, Chen ST, Lin YJ, et al. Minimal access (endoscopic and robotic) breast surgery in the surgical treatment of early breast cancer-trend and clinical outcome from a single-surgeon experience over 10 years. Front Oncol, 2021, 11: 739144.
97.	Lu S, Yang J, Wei T, et al. Single-incision endoscope-assisted breast-conserving surgery and sentinel lymph node biopsy: prospective SINA-BCS cohort study. Br J Surg, 2023, 110(9): 1076-1079.
98.	Nakajima H, Fujiwara I, Mizuta N, et al. Video-assisted skin-sparing breast-conserving surgery for breast cancer and immediate reconstruction with autologous tissue. Ann Surg, 2009, 249(1): 91-96.
99.	Noguchi M, Inokuchi M. "Moving window" operation for breast-conserving surgery. Breast Cancer, 2010, 17(1): 56-60.
100.	Ma T, Cui J, Wang Q, et al. Single-port non-lipolytic endoscopic surgery via the axillary approach for the treatment of benign breast tumors has better clinical outcomes: a case control study. BMC Womens Health, 2025, 25(1): 26.
101.	Kim JH, Ryu JM, Bae SJ, et al. Minimal access vs conventional nipple-sparing mastectomy. JAMA Surg, 2024, 159(10): 1177-1186.
102.	Soybir G, Fukuma E. Endoscopy assisted oncoplastic breast surgery (EAOBS). J Breast Health, 2015, 11(2): 52-58.
103.	周千賀, 劉健宇, 王文政, 等. 順序法純單孔腔鏡保乳術治療不同象限早期乳腺癌的療效研究. 中國修復重建外科雜志, 2024, 38(7): 793-800.Zhou QH, Liu JY, Wang WZ, et al. Effectiveness of sequential method pure single-port lumpectomy-breast conserving surgery for early-stage breast cancer in different quadrants. Chin J Repar Reconstr Surg, 2024, 38(7): 793-800.
104.	National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer. 2026.
105.	Liu J, Zhou D, Pan T, et al. Socioeconomic and clinical factors affecting the proportion of breast conserving surgery in Chinese women with breast cancer. Gland Surg, 2022, 11(2): 341-351.
106.	Putnam G, Williams T, Park S, et al. Current trends in breast cancer treatment in Chinese and Chinese American women: the disparity between mastectomy and breast reconstruction. Ann Plast Surg, 2024, 92(4): 463-468.
107.	Zhao R, Jin M, Gao J, et al. A cross-sectional study of breast cancer surgery and the cost based on data from 77 Chinese 3A hospitals in 2015. Front Oncol, 2022, 12: 857359.
108.	Quinn TT, Miller GS, Rostek M, et al. Prosthetic breast reconstruction: indications and update. Gland Surg, 2016, 5(2): 174-186.
109.	Agha-Mohammadi S, De La Cruz C, Hurwitz DJ. Breast reconstruction with alloplastic implants. J Surg Oncol, 2006, 94(6): 471-478.
110.	Smith RW, Subramaniam S, Arora JS, et al. Cost effectiveness of prophylactic mastectomy and autologous flap reconstruction in BRCA1/2-positive patients. Plast Reconstr Surg, 2025, 156(4): 521-528.
111.	Wu ZY, Han J, Kim HJ, et al. Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study. Breast Cancer Res Treat, 2022, 191(2): 365-373.
112.	Algaithy ZK, Petit JY, Lohsiriwat V, et al. Nipple sparing mastectomy: can we predict the factors predisposing to necrosis? Eur J Surg Oncol, 2012, 38(2): 125-129.
113.	De Vita R, Zoccali G, Buccheri EM, et al. Outcome evaluation after 2023 nipple-sparing mastectomies: our experience. Plast Reconstr Surg, 2017, 139(2): 335e-347e.
114.	Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci, 2004, 9: 283-289.
115.	Kung TA, Kidwell KM, Speth KA, et al. Radiation-induced skin changes after postmastectomy radiation therapy: a pilot study on indicators for timing of delayed breast reconstruction. J Reconstr Microsurg, 2019, 35(3): 209-215.
116.	Ho AY, Hu ZI, Mehrara BJ, et al. Radiotherapy in the setting of breast reconstruction: types, techniques, and timing. Lancet Oncol, 2017, 18(12): e742-e753.
117.	Tanos G, Prousskaia E, Chow W, et al. Locally advanced breast cancer: autologous versus implant-based reconstruction. Plast Reconstr Surg Glob Open, 2016, 4(2): e622.
118.	Franceschini G, Scardina L, Di Leone A, et al. Immediate prosthetic breast reconstruction after nipple-sparing mastectomy: traditional subpectoral technique versus direct-to-implant prepectoral reconstruction without acellular dermal matrix. J Pers Med, 2021, 11(2): 153.
119.	Alderman A, Gutowski K, Ahuja A, et al. ASPS clinical practice guideline summary on breast reconstruction with expanders and implants. Plast Reconstr Surg, 2014, 134(4): 648e-655e.
120.	Rizki H, Nkonde C, Ching RC, et al. Plastic surgical management of the contralateral breast in post-mastectomy breast reconstruction. Int J Surg, 2013, 11(9): 767-772.
121.	Casella D, Fusario D, Cassetti D, et al. Controlateral symmetrisation in SRM for breast cancer: now or then? Immediate versus delayed symmetrisation in a two-stage breast reconstruction. Curr Oncol, 2022, 29(12): 9391-9400.
122.	Lee KT, Mun GH. Prosthetic breast reconstruction in previously irradiated breasts: a meta-analysis. J Surg Oncol, 2015, 112(5): 468-475.
123.	Tan S, Lim J, Yek J, et al. The deep inferior epigastric perforator and pedicled transverse rectus abdominis myocutaneous flap in breast reconstruction: a comparative study. Arch Plast Surg, 2013, 40(3): 187-191.
124.	Tran BNN, Fadayomi A, Lin SJ, et al. Cost analysis of postmastectomy reconstruction: a comparison of two staged implant reconstruction using tissue expander and acellular dermal matrix with abdominal-based perforator free flaps. J Surg Oncol, 2017, 116(4): 439-447.
125.	National Cancer Institute. SEER cancer statistics review, 1975-2021. National Cancer Institute, 2024.
126.	Zhao J, Bian S, Di X, et al. A nomogram and risk classification system predicting the prognosis of patients with de novo metastatic breast cancer undergoing immediate breast reconstruction: a surveillance, epidemiology, and end results population-based study. Curr Oncol, 2023, 31(1): 115-131.
127.	Weiss A, Chu CK, Lin H, et al. Reconstruction in the metastatic breast cancer patient: results from the national cancer database. Ann Surg Oncol, 2018, 25(11): 3125-3133.
128.	Asaad M, Meaike J, Yonkus J, et al. Breast reconstruction in the setting of stage 4 breast cancer: is it worthwhile? Ann Surg Oncol, 2020, 27(12): 4730-4739.
129.	Sue GR, Lee GK. Mastectomy skin necrosis after breast reconstruction: a comparative analysis between autologous reconstruction and implant-based reconstruction. Ann Plast Surg, 2018, 80(5S Suppl 5): S285-S287.
130.	Jin R, Luo X, Wang X, et al. Complications and treatment strategy after breast augmentation by polyacrylamide hydrogel injection: summary of 10-year clinical experience. Aesthetic Plast Surg, 2018, 42(2): 402-409.
131.	Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg, 2006, 118(3 Suppl): 7S-14S.
132.	Chen L, Sha L, Huang SP, et al. Treatment for displacement of PAAG mixture after injection augmentation mammoplasty. Int J Clin Exp Med, 2015, 8(3): 3360-3367.
133.	Ono S, Ogawa R, Hyakusoku H. Complications after polyacrylamide hydrogel injection for soft-tissue augmentation. Plast Reconstr Surg, 2010, 126(4): 1349-1357.
134.	Shen H, Lv Y, Xu JH, et al. Complications after polyacrylamide hydrogel injection for facial soft-tissue augmentation in China: twenty-four cases and their surgical management. Plast Reconstr Surg, 2012, 130(2): 340e-348e.
135.	Unukovych D, Khrapach V, Wickman M, et al. Polyacrylamide gel injections for breast augmentation: management of complications in 106 patients, a multicenter study. World J Surg, 2012, 36(4): 695-701.
136.	Luo SK, Chen GP, Sun ZS, et al. Our strategy in complication management of augmentation mammaplasty with polyacrylamide hydrogel injection in 235 patients. J Plast Reconstr Aesthet Surg, 2011, 64(6): 731-737.
137.	Xi TF, Fan CX, Feng XM, et al. Cytotoxicity and altered c-myc gene expression by medical polyacrylamide hydrogel. J Biomed Mater Res A, 2006, 78(2): 283-290.
138.	翟曉建, 倪鳴, 王征. 聚丙烯酰胺水凝膠注射隆乳后哺乳期乳腺感染的特點與治療. 中華醫院感染學雜志, 2014, 24(15): 3804-3806.Zhai XJ, Ni M, Wang Z. Characteristics and treatment of breast infection during lactation after augmentation mammoplasty with polyacrylamide hydrogel injection. Chin J Nosocomiol, 2014, 24(15): 3804-3806.
139.	Cheng NX, Liu LG, Hui L, et al. Breast cancer following augmentation mammaplasty with polyacrylamide hydrogel (PAAG) injection. Aesthetic Plast Surg, 2009, 33(4): 563-569.
140.	Xiao ZB, Liu Y. The relationship between breast cancer and breast augmentation with injected polyacrylamide gel: two case reports. J Plast Reconstr Aesthet Surg, 2008, 61(8): 981-982.
141.	Godwin Y, Duncan RT, Feig C, et al. Soft, brown rupture: clinical signs and symptoms associated with ruptured PIP breast implants. Plast Reconstr Surg Glob Open, 2014, 2(11): e249.
142.	Kim CH. Asian outcomes of primary breast augmentation in 162 consecutive cases by a single surgeon. Plast Reconstr Surg Glob Open, 2015, 3(10): e537.
143.	Ding F, Zhao F, Jin R, et al. Management of complications in 257 cases of breast augmentation with polyacrylamide hydrogel, using two different strategies: a retrospective study. Aesthetic Plast Surg, 2022, 46(5): 2107-2121.
144.	Qian B, Xiong L, Guo K, et al. Comprehensive management of breast augmentation with polyacrylamide hydrogel injection based on 15 years of experience: a report on 325 cases. Ann Transl Med, 2020, 8(7): 475.
145.	Chen G, Wang Y, Huang JL. Breast cancer following polyacrylamide hydrogel injection for breast augmentation: a case report. Mol Clin Oncol, 2016, 4(3): 433-435.
146.	張晴, 謝妍妍, 梁法清, 等. 逆序腔鏡和傳統開放雙乳腺體切除聯合全胸肌后假體乳房重建術療效對比研究. 中國實用外科雜志, 2024, 44(11): 1263-1268.Zhang Q, Xie YY, Liang FQ, et al. Comparative analysis of efficacy of reverse sequence endoscopic and conventional open bilateral mastectomy with total subpectoral implant-based breast reconstruction. Chin J Pract Surg, 2024, 44(11): 1263-1268.
147.	Yu L, Wang J, Zhang B, et al. Treatment of breast injection with polyacrylamide hydrogel with infiltrated fascia capsule removal: report on 104 cases. Aesthetic Plast Surg, 2012, 36(5): 1120-1127.
148.	鐘家媛, 楊煥佐, 謝妍妍, 等. 腔鏡奧美定取出聯合或不聯合即刻胸肌前假體植入隆胸療效比較. 中國修復重建外科雜志, 2024, 38(7): 807-812.Zhong JY, Yang HZ, Xie YY, et al. Effectiveness comparison of endoscopic removal of injectable Amazingel with/without immediate prepectoral implant-based breast augmentation. Chin J Repar Reconstr Surg, 2024, 38(7): 807-812.
149.	黃渭清, 王智, 宋可新, 等. 奧美定注射隆乳取出后二期假體隆乳術的療效觀察. 中國美容整形外科雜志, 2017, 28(7): 400-403.Huang WQ, Wang Z, Song KX, et al. Efficacy of second-stage breast augmentation after polyacrylamide hydrogel removal. Chin J Aesthet Plast Surg, 2017, 28(7): 400-403.
150.	Panchal H, Matros E. Current trends in postmastectomy breast reconstruction. Plast Reconstr Surg, 2017, 140(5S): 7S-13S.
151.	Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med, 1997, 337(14): 949-955.
152.	Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med, 1997, 337(14): 956-962.
153.	Moo TA, McMillan R, Lee M, et al. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Ann Surg Oncol, 2013, 20(10): 3169-3174.
154.	EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 2014, 383(9935): 2127-2135.
155.	Cordeiro PG, Albornoz CR, McCormick B, et al. The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: an analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years. Plast Reconstr Surg, 2014, 134(4): 588-595.
156.	Lam TC, Borotkanics R, Hsieh F, et al. Immediate two-stage prosthetic breast reconstruction failure: radiation is not the only culprit. Plast Reconstr Surg, 2018, 141(6): 1315-1324.
157.	Hvilsom GB, H?lmich LR, Steding-Jessen M, et al. Delayed breast implant reconstruction: is radiation therapy associated with capsular contracture or reoperations? Ann Plast Surg, 2012, 68(3): 246-252.
158.	Ho AL, Bovill ES, Macadam SA, et al. Postmastectomy radiation therapy after immediate two-stage tissue expander/implant breast reconstruction: a University of British Columbia perspective. Plast Reconstr Surg, 2014, 134(1): 1e-10e.
159.	Nava MB, Pennati AE, Lozza L, et al. Outcome of different timings of radiotherapy in implant-based breast reconstructions. Plast Reconstr Surg, 2011, 128(2): 353-359.
160.	Cordeiro PG, Pusic AL, Disa JJ, et al. Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg, 2004, 113(3): 877-881.
161.	Cordeiro PG, Albornoz CR, McCormick B, et al. What is the optimum timing of postmastectomy radiotherapy in two-stage prosthetic reconstruction: radiation to the tissue expander or permanent implant? Plast Reconstr Surg, 2015, 135(6): 1509-1517.
162.	Kim M, Khavanin N, Jiang CZ, et al. Reconstructing failure: assessing surgical and patient-reported outcomes after loss of initial breast reconstruction. Plast Reconstr Surg, 2025, 155(4): 649e-659e.
163.	Devalia HL, Mansfield L. Radiotherapy and wound healing. Int Wound J, 2008, 5(1): 40-44.
164.	Serra-Mestre JM, Fernandez Pe?uela R, D’Andrea F, et al. Endoscopic delayed breast reconstruction with expanders and implants via the axillary incision made for sentinel lymph node biopsy or lymphadenectomy. Ann Plast Surg, 2018, 80(2): 100-103.
165.	Zhang Q, Liang F, Li J, et al. Clinical outcomes and aesthetic results of reverse sequence endoscopic versus traditional bilateral nipple-sparing mastectomy with immediate implant-based breast reconstruction-an analysis of initial 116 patients from single institution. Front Oncol, 2025, 15: 1496592.
166.	Chen D, Chen J, Huang Y, et al. Comparative analysis of surgical modalities for the gynecomastia treatment: efficiency and aesthetic outcomes. Andrology, 2024, 12(6): 1398-1407.
167.	Rahmani S, Turton P, Shaaban A, et al. Overview of gynecomastia in the modern era and the Leeds Gynaecomastia Investigation algorithm. Breast J, 2011, 17(3): 246-255.
168.	Koch T, Br?uner EV, Busch AS, et al. Marked increase in incident gynecomastia: a 20-year National registry study, 1998 to 2017. J Clin Endocrinol Metab, 2020, 105(10): dgaa440.
169.	Cohen PG. The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt: a major factor in the genesis of morbid obesity. Med Hypotheses, 1999, 52(1): 49-51.
170.	Liu C, Tong Y, Sun F, et al. Endoscope-assisted minimally invasive surgery for the treatment of glandular gynecomastia. Aesthetic Plast Surg, 2022, 46(6): 2655-2664.
171.	Yao Y, Yang Y, Liu J, et al. Vacuum-assisted minimally invasive surgery: an innovative method for the operative treatment of gynecomastia. Surgery, 2019, 166(5): 934-939.
172.	Diao X, Wang M, Chen D, et al. A comparative study on the short-term and long-term efficacy of endoscopic lipolysis, liposuction, and traditional open excision in gynecomastia treatment. BMC Endocr Disord, 2025, 25(1): 48.
173.	Wang YC, Huang SH, Chen FM, et al. Effective minimally invasive strategy for mixed-type gynecomastia using vacuum-assisted mastectomy and power-assisted liposuction. J Plast Reconstr Aesthet Surg, 2024, 99: 175-184.
174.	Tukenmez M, Emiroglu S, Kozanoglu E, et al. Single axillary incision endoscopic surgery and liposuction for gynecomastia. Medicine (Baltimore), 2023, 102(7): e33020.
175.	Chengyu L, Jian Z, Xiaoxin J, et al. Experience of a large series of mastoscopic axillary lymph node dissection. J Surg Oncol, 2008, 98(2): 89-93.
176.	Kühn T, Santjohanser C, Koretz K, et al. Axilloscopy and endoscopic sentinel node detection in breast cancer patients. Surg Endosc, 2000, 14(6): 573-577.
177.	Liang Y, Xu S. Nonliposuction endoscopic sentinel lymph node biopsy through the periareolar incision. Surg Innov, 2020, 27(6): 570-579.
178.	Hussein O, El-Nahhas W, El-Saed A, et al. Video-assisted axillary surgery for cancer: non-randomized comparison with conventional techniques. Breast, 2007, 16(5): 513-519.
179.	Wang ZH, Gang TR, Wu SS, et al. Single-port endoscopic-sentinellymph node biopsy combined with indocyanine green and carbonnanoparticles in breast cancer. Surg Endosc, 2023, 37(10): 7591-7599.
180.	Fang J, Ma L, Zhang YH, et al. Endoscopic sentinel lymph nodebiopsy and endoscopic axillary lymphadenectomy withoutliposuction in patients with early stage breast cancer. Surg Oncol, 2017, 26(4): 338-344.
181.	Yao CC, Liu C, Xian J. Comparison of single-pore non-liposuction near-infrared laparoscopy with conventional open surgery for axillary sentinel lymph node biopsy in patients with early breast cancer: a single-center, small-sample retrospective study. World J Surg Oncol, 2023, 21(1): 66.
182.	Ito K, Kanai T, Gomi K, et al. Endoscopic-assisted skin-sparing mastectomy combined with sentinel node biopsy. ANZ J Surg, 2008, 78(10): 894-898.
183.	Yamashita K, Shimizu K. Endoscopic video-assisted breast surgery: procedures and short-term results. J Nippon Med Sch, 2006, 73(4): 193-202.
184.	Mok CW, Lai HW. Endoscopic-assisted surgery in the management of breast cancer: 20 years review of trend, techniques and outcomes. Breast, 2019, 46: 144-156.
185.	Tamaki Y, Sakita I, Miyoshi Y, et al. Transareolar endoscopy-assisted partial mastectomy: a preliminary report of six cases. Surg Laparosc Endosc Percutan Tech, 2001, 11(6): 356-362.
186.	Lai HW, Chen ST, Liao CY, et al. Oncologic outcome of endoscopic assisted breast surgery compared with conventional approach in breast cancer: an analysis of 3426 primary operable breast cancer patients from single institute with and without propensity score matching. Ann Surg Oncol, 2021, 28(12): 7368-7380.
187.	Lai HW, Mok CW, Chang YT, et al. Endoscopic assisted breast conserving surgery for breast cancer: clinical outcome, learning curve, and patient reported aesthetic results from preliminary 100 procedures. Eur J Surg Oncol, 2020, 46(8): 1446-1455.
188.	Leff DR, Vashisht R, Yongue G, et al. Endoscopic breast surgery: where are we now and what might the future hold for video-assisted breast surgery? Breast Cancer Res Treat, 2011, 125(3): 607-625.
189.	Sae-Lim C, Lai HW, Chennavasin P, et al. Single-port three-dimensional endoscopic-assisted axillary lymph node dissection (S-P 3D E-ALND): surgical technique and preliminary results. Breast J, 2024: 6319218.
190.	Chen Y, Xu J, Liang Y, et al. A challenging therapeutic method for breast cancer: non-lipolytic endoscopic axillary surgery through periareolar incisions. Oncol Lett, 2020, 19(6): 4088-4092.
191.	de Wilde RL, Schmidt EH, Hesseling M, et al. Comparison of classic and endoscopic lymphadenectomy for staging breast cancer. J Am Assoc Gynecol Laparosc, 2003, 10(1): 75-79.
192.	Xiong H, Chen Z, Xu L, et al. Contrast of mastoscopic and conventional axillary lymph node dissection of patients with breast cancer: meta-analysis. Cancer Control, 2020, 27(2): 1073274820932987.
193.	張會強, 李健斌, 李曼, 等. 《CSCO乳腺癌診療指南2025》更新要點解讀. 中國腫瘤外科雜志, 2025, 17(3): 209-215.Zhang HQ, Li JB, Li M, et al. Interpretation of key updates in the 2025 Chinese Society of Clinical Oncology (CSCO) breast cancer diagnosis and treatment guidelines. Chin J Surg Oncol, 2025, 17(3): 209-215.
194.	Lerman BJ, Popat RA, Assimes TL, et al. Association of left ventricular ejection fraction and symptoms with mortality after elective noncardiac surgery among patients with heart failure. JAMA, 2019, 321(6): 572-579.
195.	張思憶, 趙若寒, 婁杰, 等. 左心室功能第一階段射血分數的臨床研究進展. 臨床心血管病雜志, 2024, 40(11): 888-892.Zhang SY, Zhao RH, Lou J, et al. Clinical application progress of first phase ejection fraction. J Clin Cardiol, 2024, 40(11): 888-892.
196.	Roy PM. Preoperative pulmonary evaluation for lung resection. J Anaesthesiol Clin Pharmacol, 2018, 34(3): 296-300.
197.	Roungeris L, Devadze G, Talliou C, et al. Prediction of postoperative complications after major lung resection: a literature review. Anesth Res, 2024, 1(2): 146-156.
198.	Licker MJ, Widikker I, Robert J, et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg, 2006, 81(5): 1830-1837.
199.	桂文萍, 崔宇航, 喬麗娟, 等. 改良 L 型肢體支撐架在腔鏡乳腺癌手術 "望月式" 體位中的應用. 護理學雜志, 2023, 38(10): 47-49.Gui WP, Cui YH, Qiao LJ, et al. Application of modified "L" type limb support in the "looking at the moon" position of endoscopic breast cancer surgery. J Nurs Sci, 2023, 38(10): 47-49.
200.	張霞, 王妙維, 李果, 等. 漸進式康復訓練對乳腺癌乳房重建患者上肢功能的影響. 中國康復, 2023, 38(12): 720-723.Zhang X, Wang MW, Li G, et al. Effects of progressive rehabilitation training on upper limb function of patients with breast cancer undergoing breast re-construction surgery . Chin J Rehabil, 2023, 38(12): 720-723.
201.	She LC, Wang HY, Liu MF, et al. The relationship between self-perceived health and clinical symptoms in patients with frozen shoulders. Int J Environ Res Public Health, 2022, 19(21): 14396.
202.	Wei TS. Endoscopy-assisted breast surgery for breast cancer. In: Mastering Endo-Laparoscopic and Thoracoscopic Surgery: ELSA Manual. Singapore: Springer, 2022: 169-173.
203.	中國醫師協會微無創分會乳腺專家委員會. 乳腺疾病腔鏡手術專家共識及操作指南(2021版). 中國微創外科雜志, 2021, 21(12): 1057-1067.Breast Expert Committee, Minimally Invasive and Non-invasive Branch of Chinese Medical Doctor Association. Expert consensus and operation guide for endoscopic surgery of breast diseases (2021 edition). Chin J Min Invasive Surg, 2021, 21(12): 1057-1067.
204.	Kusunose M, Inui A, Nishimoto H, et al. Measurement of shoulder abduction angle with posture estimation artificial intelligence model. Sensors (Basel), 2023, 23(14): 6445.
205.	顧麗英, 馮靜英. 團體健康教育對乳腺癌術后患肢功能鍛煉的效果觀察. 上海預防醫學, 2016, 28(8): 585-587.Gu LY, Feng JY. Observation of the effect of group health education on functional exercise of affected limbs after breast cancer surgery. Shanghai J Prev Med, 2016, 28(8): 585-587.
206.	陳允允, 張男, 董曉晶, 等. 專科護士主導的團隊合作模式促進乳腺癌患者上肢功能康復. 護理學雜志, 2022, 35(17): 75-79.Chen YY, Zhang N, Dong XJ, et al. The effect of specialized nurse-led teamwork model in the recovery of upper-limb motor function in breast cancer patients. J Nurs Sci, 2022, 35(17): 75-79.
207.	National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer (version 2.2025). 2025.
208.	Urban C, Rietjens M, El-Tamer M, et al. Oncoplastic and Reconstructive Breast Surgery (second edition). Cham: Springer, 2019.
209.	陳莉明, 陳偉, 陳燕燕, 等. 成人圍手術期血糖監測專家共識. 中國糖尿病雜志, 2021, 29(2): 81-85.Chen LM, Chen W, Chen YY, et al. Expert consensus on perioperative blood glucose monitoring in adults. Chin J Diabetes, 2021, 29(2): 81-85.
210.	White L. Peri-operative management of the surgical patient with diabetes: a guideline summary. 2016.
211.	Membership of the Working Party, Barker P, Creasey PE, et al. Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia, 2015, 70(12): 1427-1440.
212.	Hart A, Funderburk CD, Chu CK, et al. The impact of diabetes mellitus on wound healing in breast reconstruction. Ann Plast Surg, 2017, 78(3): 260-263.
213.	Liu Q, Aggarwal A, Wu M, et al. Impact of diabetes on outcomes in breast reconstruction: a systematic review and meta-analysis. J Plast Reconstr Aesthet Surg, 2022, 75(6): 1793-1804.
214.	Zucker I, Bouz A, Castro G, et al. Smoking as a risk factor for surgical site complications in implant-based breast surgery. Cureus, 2021, 13(10): e18876.
215.	Prantl L, Moellhoff N, Fritschen UV, et al. Impact of smoking status in free deep inferior epigastric artery perforator flap breast reconstruction: a multicenter study. J Reconstr Microsurg, 2020, 36(9): 694-702.
216.	Chang DW, Reece GP, Wang B, et al. Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg, 2000, 105(7): 2374-2380.
217.	Park HS, Lee J, Lai HW, et al. Surgical and oncologic outcomes of robotic and conventional nipple-sparing mastectomy with immediate reconstruction: international multicenter pooled data analysis. Ann Surg Oncol, 2022, 29(11): 6646-6657.
218.	He X, Hou L, Wang D, et al. Clinical application of endoscopic radical mastectomy for breast cancer combined with total pectoral muscle reconstruction with breast implants. Chin J Repar Reconstr Surg, 2024, 38(7): 786-792.
219.	Wan A, Liang Y, Chen L, et al. Association of long-term oncologic prognosis with minimal access breast surgery vs conventional breast surgery. JAMA Surg, 2022, 157(12): e224711.
220.	Xu X, Gao X, Pan C, et al. Postoperative outcomes of minimally invasive versus conventional nipple-sparing mastectomy with prosthesis breast reconstruction in breast cancer: a meta-analysis. J Robot Surg, 2024, 18(1): 274.
221.	Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med, 1990, 322(3): 153-160.
222.	Bold RJ, Mansfield PF, Berger DH, et al. Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. Am J Surg, 1998, 176(3): 239-243.
223.	Gulluoglu BM, Guler SA, Ugurlu MU, et al. Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients: a randomized controlled trial. Ann Surg, 2013, 257(1): 37-43.
224.	Phillips BT, Fourman MS, Bishawi M, et al. Are prophylactic postoperative antibiotics necessary for immediate breast reconstruction? Results of a prospective randomized clinical trial. J Am Coll Surg, 2016, 222(6): 1116-1124.
225.	Gahm J, Ljung Konstantinidou A, Lagergren J, et al. Effectiveness of single vs multiple doses of prophylactic intravenous antibiotics in implant-based breast reconstruction: a randomized clinical trial. JAMA Netw Open, 2022, 5(9): e2231583.
226.	Hinson C, Sink M, Sammer D, et al. Extended antibiotic prophylaxis in implant-based breast reconstruction: a systematic review and meta-analysis. Aesthet Surg J, 2025, 45(11): 1152-1158.
227.	In SK, Park SW, Myung Y. Effect of perioperative prophylactic intravenous antibiotic use in immediate implant-based breast reconstruction: a retrospective matched cohort study. Arch Plast Surg, 2024, 51(1): 36-41.
228.	Du X, Duan X, Zhou X, et al. A study on the correlation between MRI-assessed breast volume asymmetry and patient satisfaction after immediate breast reconstruction in breast cancer patients. Sci Rep, 2024, 14(1): 30737.
229.	Bassetto F, Pandis L, Facchin F, et al. Braxon?-assisted prepectoral breast reconstruction: a decade later. Front Surg, 2022, 9: 1009356.
230.	Taj S, Chandavarkar R, Vidya R. Current global trends in prepectoral breast reconstruction. Medicina (Kaunas), 2024, 60(3): 431.
231.	Liu LQ, Branford OA, Mehigan S. BREAST-Q measurement of the patient perspective in oncoplastic breast surgery: a systematic review. Plast Reconstr Surg Glob Open, 2018, 6(8): e1904.
232.	Baek WY, Byun IH, Kim YS, et al. Patient satisfaction with implant based breast reconstruction associated with implant volume and mastectomy specimen weight ratio. J Breast Cancer, 2017, 20(1): 98-103.
233.	Ma JX, Xia YC, Li B, et al. Unilateral tissue expander/implant two-stage breast reconstruction with the assistance of three-dimensional surface imaging. Aesthetic Plast Surg, 2020, 44(1): 60-69.
234.	馬建勛, 夏有辰, 李比. 乳房再造術中的假體選擇策略. 組織工程與重建外科, 2023, 19(2): 152-156.Ma JX, Xia YC, Li B. Prosthesis selection strategy in breast reconstruction. J Tissue Eng Reconstr Surg, 2023, 19(2): 152-156.
235.	Dai H, Cao X, Wu H, et al. Reverse-sequence endoscopic nipple-sparing mastectomy with direct-to-implant breast reconstruction and air inflation adjustment technique in patients with large or severely ptotic breast: a single-center prospective cohort study. Int J Surg, 2025, 111(6): 3838-3849.
236.	Qiu J, Wen N, Xie Y, et al. Novel technique for endoscopic-assisted nipple-sparing mastectomy and immediate breast reconstruction with endoscopic-assisted latissimus dorsi muscle flap harvest through a single axillary incision: a retrospective cohort study of comparing endoscopic and open surgery. Gland Surg, 2022, 11(8): 1383-1394.
237.	駱成玉, 劉寶胤. 乳腔鏡男子乳腺發育微創手術專家共識及操作指南 (2019 版). 中國微創外科雜志, 2019, 19(11): 961-963.Luo CY, Liu BY. Expert consensus and operation guide for minimally invasive endoscopic surgery for gynecomastia (2019 edition). Chin J Min Invasive Surg, 2019, 19(11): 961-963.
238.	中國抗癌協會乳腺癌專業委員會, 中國醫師協會外科醫師分會, 上海市抗癌協會乳腺癌專業委員會. 乳腺腫瘤整形與乳房重建專家共識 (2022年版). 中國癌癥雜志, 2022, 32(9): 836-892.China Anti-Cancer Association, the Society of Breast Cancer; Breast Surgeons Committee of Surgeons Branch, Chinese Medical Doctor Association; Committee of Breast Cancer Society, Shanghai Anti-Cancer Association. Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition). China Oncol, 2022, 32(9): 836-892.
239.	王子函, 毛開源, 謝菲. 腔鏡胸肌前假體乳房重建術技術要點. 中國實用外科雜志, 2024, 44(11): 1215-1219.Wang ZH, Mao KY, Xie F. Technical key points of endoscopic prepectoral breast reconstruction with implants. Chin J Pract Surg, 2024, 44(11): 1215-1219.
240.	唐鵬, 何佳玲. 《乳腺腫瘤整形與乳房重建專家共識 (2022年版) 》腔鏡手術部分解讀. 中國實用外科雜志, 2024, 44(11): 1243-1245.Tang P, He JL. Interpretation of expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition). Chin J Pract Surg, 2024, 44(11): 1243-1245.
241.	Dua MM, Bertoni DM, Nguyen D, et al. Using intraoperative laser angiography to safeguard nipple perfusion in nipple-sparing mastectomies. Gland Surg, 2015, 4(6): 497-505.
242.	Pruimboom T, Schols RM, Van Kuijk SM, et al. Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction. Cochrane Database Syst Rev, 2020, 4(4): CD013280.
243.	Elmelegy N, Shokr T, Osama M. Nipple-areola complex ischemia or necrosis in freestyle perforator flap reduction mammoplasty operations. Aesthetic Plast Surg, 2019, 43(6): 1506-1514.
244.	Zhou J, Liu X, Feng Y, et al. Breakthrough in breast reconstruction in the context of COVID-19: safety and efficiency of endoscopic breast reconstruction at a day surgery center. Gland Surg, 2021, 10(8): 2477-2489.
245.	Lai HW, Chen ST, Mok CW, et al. Single-port three-dimensional (3D) videoscope-assisted endoscopic nipple-sparing mastectomy in the management of breast cancer: technique, clinical outcomes, medical cost, learning curve, and patient-reported aesthetic results from 80 preliminary procedures. Ann Surg Oncol, 2021, 28(12): 7331-7344.
246.	Lai HW, Lin SL, Chen ST, et al. Single-axillary-incision endoscopic-assisted hybrid technique for nipple-sparing mastectomy: technique, preliminary results, and patient-reported cosmetic outcome from preliminary 50 procedures. Ann Surg Oncol, 2018, 25(5): 1340-1349.
247.	Zhang S, Xie Y, Liang F, et al. Video-assisted transaxillary nipple-sparing mastectomy and immediate implant-based breast reconstruction: a novel and promising method. Aesthetic Plast Surg, 2022, 46(1): 91-98.
248.	中國抗癌協會腫瘤整形外科專業委員會, 中國抗癌協會腫瘤麻醉與鎮痛專業委員會. 乳房再造加速康復外科中國專家共識 (2022版). 中國腫瘤臨床, 2023, 50(8): 379-384.Committee of Oncoplastic Surgery, Chinese Anti-Cancer Association; Committee of Oncologic Anesthesia and Analgesia, Chinese Anti-Cancer Association. Chinese expert consensus on enhanced recovery after surgery in breast reconstruction (2022 edition). Chin J Clin Oncol, 2023, 50(8): 379-384.
249.	Alabaster K, Homsy C, Puyana S, et al. Exercise after breast reconstruction surgery: evaluating current trends and practices of U. S. plastic surgeons. Plast Reconstr Surg Glob Open, 2021, 9(10): e3857.
250.	De Groef A, Van Kampen M, Dieltjens E, et al. Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil, 2015, 96(6): 1140-1153.
251.	Bruce J, Mazuquin B, Mistry P, et al. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT. Health Technol Assess, 2022, 26(15): 1-124.
252.	Chua C, Bascone CM, Pereira C, et al. Final 24-hour drain output and postoperative day are poor indicators for appropriate drain removal. Plast Reconstr Surg Glob Open, 2022, 10(4): e4160.
253.	Chen CF, Lin SF, Hung CF, et al. Risk of infection is associated more with drain duration than daily drainage volume in prosthesis-based breast reconstruction: a cohort study. Medicine (Baltimore), 2016, 95(49): e5605.
254.	Lembo F, Cecchino LR, Parisi D, et al. Reduction of seroma and improvement of quality of life after early drain removal in immediate breast reconstruction with tissue expander. Preliminary report from a randomized controlled study. J Plast Reconstr Aesthet Surg, 2021, 74(10): 2565-2572.
255.	Gadiraju GK, Prospero MR, Tobias F, et al. Understanding the impacts of surgical drains on postoperative pain and quality of life. Plast Reconstr Surg Glob Open, 2025, 13(1): e6474.
256.	Sobti N, Weitzman RE, Nealon KP, et al. Evaluation of capsular contracture following immediate prepectoral versus subpectoral direct-to-implant breast reconstruction. Sci Rep, 2020, 10(1): 1137.
257.	Yang H, Liang F, Xie Y, et al. Single axillary incision reverse-order endoscopic nipple/skin-sparing mastectomy followed by subpectoral implant-based breast reconstruction: technique, clinical outcomes, and aesthetic results from 88 preliminary procedures. Surgery, 2023, 174(3): 464-472.
258.	Shammas RL, Levy J, Boe LA, et al. Risk of radiation-induced capsular contracture following subpectoral or prepectoral implant-based breast reconstruction. Plast Reconstr Surg, 2026, 157(1): 6e-14e.
259.	Sewart E, Turner NL, Conroy EJ, et al. The impact of radiotherapy on patient-reported outcomes of immediate implant-based breast reconstruction with and without mesh. Ann Surg, 2022, 275(5): 992-1001.
260.	Seth AK, Cordeiro PG. Stability of long-term outcomes in implant-based breast reconstruction: an evaluation of 12-year surgeon- and patient-reported outcomes in 3489 nonirradiated and irradiated implants. Plast Reconstr Surg, 2020, 146(3): 474-484.

1. 杜正貴, 呂青, 呂鵬威, 等. 中國腔鏡/機器人乳腺手術指南 (2026版): 第一部分. 中國胸心血管外科臨床雜志, 2026, 33(2): 167-203.Du ZG, Lü Q, Lü PW, et al. Guidelines for endoscopic and robotic breast surgery in China (2026 edition): part one. Chin J Clin Thorac Cardiovasc Surg, 2026, 33(2): 167-203.
2. 杜正貴, 呂青, 呂鵬威. 中國腔鏡/機器人乳腺手術指南(2026版) 計劃書. 中國胸心血管外科臨床雜志, 2026, 33(3): 333-338.Du ZG, Lü Q, Lü PW, et al. Protocol for China endoscopic and robotic breast surgery guidelines (2026 edition). Chin J Clin Thorac Cardiovasc Surg, 2026, 33(3): 333-338.
3. Li X, You R, Wang X, et al. Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review. Clin Cancer Res, 2016, 22(15): 3971-3981.
4. Young MO. Prophylactic simple mastectomy. Rocky Mt Med J, 1966, 63(5): 31-32.
5. Lynch HT, Shaw MW, Magnuson CW, et al. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med, 1966, 117(2): 206-212.
6. Fayanju OM, Stoll CR, Fowler S, et al. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg, 2014, 260(6): 1000-1010.
7. Srethbhakdi A, Brennan ME, Hamid G, et al. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: systematic review of patient reported outcomes. Psychooncology, 2020, 29(6): 960-973.
8. King MC. "The race" to clone BRCA1. Science, 2014, 343(6178): 1462-1465.
9. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature, 1995, 378(6559): 789-792.
10. Mavaddat N, Peock S, Frost D, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst, 2013, 105(11): 812-822.
11. Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 2017, 317(23): 2402-2416.
12. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med, 2001, 345(3): 159-164.
13. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol, 2004, 22(6): 1055-1062.
14. Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, 2010, 304(9): 967-975.
15. Blondeaux E, Sonnenblick A, Agostinetto E, et al. Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study. Lancet Oncol, 2025, 26(6): 759-770.
16. Carlson RW, Brown E, Burstein HJ, et al. NCCN Task Force report: adjuvant therapy for breast cancer. J Natl Compr Canc Netw, 2006, 4 (Suppl 1): S1-26.
17. Balma?a J, Díez O, Rubio IT, et al. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol, 2011, 22(Suppl 6): vi31-vi34.
18. Robson ME, Bradbury AR, Arun B, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol, 2015, 33(31): 3660-3667.
19. McGuire KP, Mamounas EP. Management of hereditary breast cancer: ASCO, ASTRO, and SSO guideline. Ann Surg Oncol, 2020, 27(6): 1721-1723.
20. 中國臨床腫瘤學會乳腺癌專家委員會, 中國抗癌協會乳腺癌專業委員會, 中華醫學會外科學分會乳腺外科學組. 中國年輕乳腺癌診療專家共識 (2022). 中華醫學雜志, 2023, 103(6): 387-403.Chinese Society of Clinical Oncology, Experts Committee on Breast Cancer; China Anti-Cancer Association, the Society of Breast Cancer; Chinese Medical Association, Chinese Society of Breast Surgery. Expert consensus on the diagnosis and treatment of young breast cancer in China (2022 edition). Natl Med J China, 2023, 103(6): 387-403.
21. 中國醫師協會精準治療委員會乳腺癌專業委員會, 中華醫學會腫瘤學分會乳腺腫瘤學組, 中國抗癌協會乳腺癌專業委員會, 等. 中國乳腺癌患者BRCA1/2基因檢測與臨床應用專家共識(2018年版). 中國癌癥雜志, 2018, 28(10): 787-800.Breast Cancer Professional Committee, Precision Treatment Committee of Chinese Medical Doctor Association; Breast Oncology Group, Society of Oncology, Chinese Medical Association; China Anti-Cancer Association, the Society of Breast Cancer, et al. Chinese expert consensus on BRCA1/2 gene detection and clinical application in breast cancer patients (2018 edition). China Oncol, 2018, 28(10): 787-800.
22. Kratz CP, Achatz MI, Brugières L, et al. Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res, 2017, 23(11): e38-e45.
23. Lynch HT, Watson P, Conway TA, et al. Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat, 1990, 15(2): 63-71.
24. Barnes DR, Silvestri V, Leslie G, et al. Breast and prostate cancer risks for male BRCA1 and BRCA2 pathogenic variant carriers using polygenic risk scores. J Natl Cancer Inst, 2022, 114(1): 109-122.
25. Pashayan N, Pharoah PD, Schleutker J, et al. Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. Br J Cancer, 2015, 113(7): 1086-1093.
26. Seibert TM, Fan CC, Wang Y, et al. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. BMJ, 2018, 360: j5757.
27. Kurian AW, Hare EE, Mills MA, et al. Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol, 2014, 32(19): 2001-2009.
28. Lakeman IMM, Rodríguez-Girondo MDM, Lee A, et al. Clinical applicability of the polygenic risk score for breast cancer risk prediction in familial cases. J Med Genet, 2023, 60(4): 327-336.
29. Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene, 2008, 27(41): 5387-5397.
30. Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns, 2009, 18(1): 13-27.
31. Mester J, Charis E. PTEN hamartoma tumor syndrome. Handb Clin Neurol, 2015, 132: 129-37.
32. Pilarski R, Stephens JA, Noss R, et al. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet, 2011, 48(8): 505-512.
33. Varga EA, Pastore M, Prior T, et al. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med, 2009, 11(2): 111-117.
34. Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, et al. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome. J Natl Cancer Inst, 2023, 115(1): 93-103.
35. Roberts ME, Ranola JMO, Marshall ML, et al. Comparison of CDH1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers. JAMA Oncol, 2019, 5(9): 1325-1331.
36. Ryan CE, Fasaye GA, Gallanis AF, et al. Germline CDH1 variants and lifetime cancer risk. JAMA, 2024, 332(9): 722-729.
37. Breast Cancer Association Consortium, Mavaddat N, Dorling L, et al. Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes. JAMA Oncol, 2022, 8(3): e216744.
38. Breast Cancer Association Consortium, Dorling L, Carvalho S, et al. Breast cancer risk genes: association analysis in more than113, 000 women. N Engl J Med, 2021, 384(5): 428-439.
39. Yang X, Leslie G, Doroszuk A, et al. Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol, 2020, 38(7): 674-685.
40. Marabelli M, Cheng SC, Parmigiani G. Penetrance of ATM gene mutations in breast cancer: a meta-analysis of different measures of risk. Genet Epidemiol, 2016, 40(5): 425-431.
41. Hearle N, Schumacher V, Menko FH, et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res, 2006, 12(10): 3209-3215.
42. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med, 1999, 340(2): 77-84.
43. Reiner AS, John EM, Brooks JD, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol, 2013, 31(4): 433-439.
44. Gradishar WJ, Anderson BO, Abraham J, et al. Breast cancer, version 3. 2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2020, 18(4): 452-478.
45. 中華醫學會外科學分會乳腺外科學組. 中國家族遺傳性乳腺癌行預防性乳房切除術臨床實踐指南(2024版). 中國實用外科雜志, 2024, 44(11): 1201-1205.Chinese Society of Breast Surgery, Chinese Society of Surgery, Chinese Medical Association. Guideline on the clinical practice for prophylactic mastectomy in hereditary breast cancer in China (2024 edition). Chin J Pract Surg, 2024, 44(11): 1201-1205.
46. Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA, 2003, 290(4): 465-475.
47. Henderson TO, Amsterdam A, Bhatia S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med, 2010, 152(7): 444-455.
48. National Comprehensive Cancer Network. Cancer-related fatigue. Clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2003, 1(3): 308-331.
49. Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2019, 30(8): 1194-1220.
50. Hoogerbrugge N, Bult P, de Widt-Levert LM, et al. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol, 2003, 21(1): 41-45.
51. Chuba PJ, Hamre MR, Yap J, et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol, 2005, 23(24): 5534-5541.
52. King TA, Pilewskie M, Muhsen S, et al. Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol, 2015, 33(33): 3945-3952.
53. 王濤, 江澤飛. 乳腺癌輔助治療若干問題的思考和討論—2008年《NCCN乳腺癌臨床實踐指南中國版》解讀. 臨床腫瘤學雜志, 2008, 13(9): 846-848.Wang T, Jiang ZF. Considerations and discussion on key issues in adjuvant breast cancer therapy: an interpretation of the 2008 NCCN breast cancer clinical practice guidelines (Chinese edition). Chin Clin Oncol, 2008, 13(9): 846-848.
54. Gradishar W J, Moran M S, Abraham J, et al. NCCN Guidelines insights: breast cancer, version 5. 2025. J Natl Compr Canc Netw, 2025, 23(11): 426-436.
55. 中國抗癌協會乳腺癌專業委員會, 中華醫學會腫瘤學分會乳腺腫瘤學組. 中國抗癌協會乳腺癌診治指南與規范 (2024年版). 中國癌癥雜志, 2023, 33(12): 1092-1187.China Anti-Cancer Association, the Society of Breast Cancer; Breast Oncology Group of the Oncology Branch of the Chinese Medical Association. Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition). China Oncol, 2023, 33(12): 1092-1187.
56. Karabeg R, Jakirlic M, Karabeg A, et al. The new method of pocket forming for breast implant placement in augmentation mammaplasty: dual plane subfascial. Med Arch, 2019, 73(3): 178-182.
57. Zhou J, Xie Y, Liang F, et al. A novel technique of reverse-sequence endoscopic nipple-sparing mastectomy with direct-to-implant breast reconstruction: medium-term oncological safety outcomes and feasibility of 24-h discharge for breast cancer patients. Int J Surg, 2024, 110(4): 2243-2252.
58. Lee DW, Kim SJ, Kim H. Endoscopic transaxillary versus inframammary approaches for breast augmentation using shaped implants: a matched case-control study. Aesthetic Plast Surg, 2019, 43(3): 563-568.
59. Kolker AR, Austen WG, Slavin SA. Endoscopic-assisted transaxillary breast augmentation: minimizing complications and maximizing results with improvements in patient selection and technique. Ann Plast Surg, 2010, 64(5): 667-673.
60. Stevens WG, Stoker DA, Freeman ME, et al. Is one-stage breast augmentation with mastopexy safe and effective? A review of 186 primary cases. Aesthet Surg J, 2006, 26(6): 674-681.
61. Razdan SN, Panchal H, Albornoz CR, et al. Impact of contralateral symmetry procedures on long-term patient-reported outcomes following unilateral prosthetic breast reconstruction. J Reconstr Microsurg, 2019, 35(2): 124-128.
62. Churchill IF, Gallo L, Dunn E, et al. Complications and burden of 2-stage tissue expander to implant-based reconstructive surgery: a single-center retrospective study. Plast Surg (Oakv), 2025, 33(2): 201-207.
63. Daar DA, Abdou SA, Rosario L, et al. Is there a preferred incision location for nipple-sparing mastectomy? A systematic review and meta-analysis. Plast Reconstr Surg, 2019, 143(5): 906e-919e.
64. Feng Y, Xie Y, Liang F, et al. Twenty-four-hour discharge of patients after endoscopic nipple-sparing mastectomy and direct-to-implant breast reconstruction: safety and aesthetic outcomes from a prospective cohort study. Br J Surg, 2024, 111(1): znad356.
65. Harvey KL, Sinai P, Mills N, et al. Short-term safety outcomes of mastectomy and immediate prepectoral implant-based breast reconstruction: pre-BRA prospective multicentre cohort study. Br J Surg, 2022, 109(6): 530-538.
66. Heimes AS, Stewen K, Hasenburg A. Psychosocial aspects of immediate versus delayed breast reconstruction. Breast Care (Basel), 2017, 12(6): 374-377.
67. Qiu M, Yang H, Zhou J, et al. Short-term safety and cosmetic outcomes of endoscopic direct-to-implant breast reconstruction and simultaneous contralateral breast augmentation for breast cancer: a prospective analysis of 33 patients. World J Surg Oncol, 2023, 21(1): 201.
68. Tebbetts JB. Dual plane breast augmentation: optimizing implant-soft-tissue relationships in a wide range of breast types. Plast Reconstr Surg, 2006, 118(7 Suppl): 81S-102S.
69. Tebbetts JB. Dual plane breast augmentation: optimizing implant-soft-tissue relationships in a wide range of breast types. Plast Reconstr Surg, 2001, 107(5): 1255-1272.
70. Tebbetts JB. Axillary endoscopic breast augmentation: processes derived from a 28-year experience to optimize outcomes. Plast Reconstr Surg, 2006, 118(7 Suppl): 53S-80S.
71. Graf RM, Bernardes A, Rippel R, et al. Subfascial breast implant: a new procedure. Plast Reconstr Surg, 2003, 111(2): 904-908.
72. Brown T. A comprehensive outcome review of subfascial breast augmentation over a 10-year period. Plast Reconstr Surg, 2020, 146(6): 1249-1257.
73. Gould DJ, Shauly O, Ohanissian L, et al. Subfascial breast augmentation: a systematic review and meta-analysis of capsular contracture. Aesthet Surg J Open Forum, 2020, 2(1): ojaa006.
74. von Sperling ML, H?imyr H, Finnerup K, et al. Persistent pain and sensory changes following cosmetic breast augmentation. Eur J Pain, 2011, 15(3): 328-332.
75. Tan P, Martin MS, Shank N, et al. A comparison of 4 analgesic regimens for acute postoperative pain control in breast augmentation patients. Ann Plast Surg, 2017, 78(6 Suppl 5): S299-S304.
76. Govrin-Yehudain O, Matanis Y, Govrin-Yehudain J. Reduced pain and accelerated recovery following primary breast augmentation with lightweight breast implants. Aesthet Surg J, 2018, 38(10): 1092-1096.
77. Kang CM, Kim WJ, Yoon SH, et al. Postoperative pain control by intercostal nerve block after augmentation mammoplasty. Aesthetic Plast Surg, 2017, 41(5): 1031-1036.
78. Fredman R, Wu C, Rapolti M, et al. Prepectoral direct-to-implant breast reconstruction: early outcomes and analysis of postoperative pain. Aesthet Surg J Open Forum, 2019, 1(1): ojz006.
79. Ciftci B, Ekinci M, Celik EC, et al. Ultrasound-guided pectoral nerve block for pain control after breast augmentation: a randomized clinical study. Braz J Anesthesiol, 2021, 71(1): 44-49.
80. Sforza M, Saghir R, Saghir N, et al. Assessing the efficacy of the S-PECS block in breast augmentation surgery: a randomized, double-blind, controlled trial. Plast Reconstr Surg, 2024, 153(1): 1e-9e.
81. Graf RM, Bernardes A, Auersvald A, et al. Subfascial endoscopic transaxillary augmentation mammaplasty. Aesthetic Plast Surg, 2000, 24(3): 216-220.
82. Pereira LH, Sterodimas A. Transaxillary breast augmentation: a prospective comparison of subglandular, subfascial, and submuscular implant insertion. Aesthetic Plast Surg, 2009, 33(5): 752-759.
83. Aygit AC, Basaran K, Mercan ES. Transaxillary totally subfascial breast augmentation with anatomical breast implants: review of 27 cases. Plast Reconstr Surg, 2013, 131(5): 1149-1156.
84. Sim HB. Revisiting prepectoral breast augmentation: indications and refinements. Aesthet Surg J, 2019, 39(5): NP113-NP122.
85. Yuan M, Kim P, Gallo L, et al. Outcomes in subfascial versus subglandular planes in breast augmentation: a systematic review and meta-analysis. Aesthet Surg J, 2024, 44(9): NP639-NP644.
86. Shen Z, Chen X, Sun J, et al. A comparative assessment of three planes of implant placement in breast augmentation: a bayesian analysis. J Plast Reconstr Aesthet Surg, 2019, 72(12): 1986-1995.
87. Sim HB. Transaxillary endoscopic breast augmentation. Arch Plast Surg, 2014, 41(5): 458-465.
88. Lista F, Ahmad J. Evidence-based medicine: augmentation mammaplasty. Plast Reconstr Surg, 2013, 132(6): 1684-1696.
89. Schwartz MR. Evidence-based medicine: breast augmentation. Plast Reconstr Surg, 2017, 140(1): 109e-119e.
90. Wong CH, Samuel M, Tan BK, et al. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg, 2006, 118(5): 1224-1236.
91. Ostapenko E, Nixdorf L, Devyatko Y, et al. Prepectoral versus subpectoral implant-based breast reconstruction: a systemic review and meta-analysis. Ann Surg Oncol, 2023, 30(1): 126-136.
92. Benito-Ruiz J, Manzano ML, Salvador-Miranda L. Five-year outcomes of breast augmentation with form-stable implants: periareolar vs transaxillary. Aesthet Surg J, 2017, 37(1): 46-56.
93. Shi H, Cao C, Li X, et al. A retrospective study of primary breast augmentation: recovery period, complications and patient satisfaction. Int J Clin Exp Med, 2015, 8(10): 18737-18743.
94. Bak K, Cameron EA, Henderson IJ. Rupture of the pectoralis major: a meta-analysis of 112 cases. Knee Surg Sports Traumatol Arthrosc, 2000, 8(2): 113-119.
95. Li L, Liang Y, Li C, et al. Comparison of endoscopic breast-conserving surgery versus conventional breast-conserving surgery for the treatment of early-stage breast cancer: a meta-analysis. Front Oncol, 2024, 14: 1419123.
96. Lai HW, Chen ST, Lin YJ, et al. Minimal access (endoscopic and robotic) breast surgery in the surgical treatment of early breast cancer-trend and clinical outcome from a single-surgeon experience over 10 years. Front Oncol, 2021, 11: 739144.
97. Lu S, Yang J, Wei T, et al. Single-incision endoscope-assisted breast-conserving surgery and sentinel lymph node biopsy: prospective SINA-BCS cohort study. Br J Surg, 2023, 110(9): 1076-1079.
98. Nakajima H, Fujiwara I, Mizuta N, et al. Video-assisted skin-sparing breast-conserving surgery for breast cancer and immediate reconstruction with autologous tissue. Ann Surg, 2009, 249(1): 91-96.
99. Noguchi M, Inokuchi M. "Moving window" operation for breast-conserving surgery. Breast Cancer, 2010, 17(1): 56-60.
100. Ma T, Cui J, Wang Q, et al. Single-port non-lipolytic endoscopic surgery via the axillary approach for the treatment of benign breast tumors has better clinical outcomes: a case control study. BMC Womens Health, 2025, 25(1): 26.
101. Kim JH, Ryu JM, Bae SJ, et al. Minimal access vs conventional nipple-sparing mastectomy. JAMA Surg, 2024, 159(10): 1177-1186.
102. Soybir G, Fukuma E. Endoscopy assisted oncoplastic breast surgery (EAOBS). J Breast Health, 2015, 11(2): 52-58.
103. 周千賀, 劉健宇, 王文政, 等. 順序法純單孔腔鏡保乳術治療不同象限早期乳腺癌的療效研究. 中國修復重建外科雜志, 2024, 38(7): 793-800.Zhou QH, Liu JY, Wang WZ, et al. Effectiveness of sequential method pure single-port lumpectomy-breast conserving surgery for early-stage breast cancer in different quadrants. Chin J Repar Reconstr Surg, 2024, 38(7): 793-800.
104. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer. 2026.
105. Liu J, Zhou D, Pan T, et al. Socioeconomic and clinical factors affecting the proportion of breast conserving surgery in Chinese women with breast cancer. Gland Surg, 2022, 11(2): 341-351.
106. Putnam G, Williams T, Park S, et al. Current trends in breast cancer treatment in Chinese and Chinese American women: the disparity between mastectomy and breast reconstruction. Ann Plast Surg, 2024, 92(4): 463-468.
107. Zhao R, Jin M, Gao J, et al. A cross-sectional study of breast cancer surgery and the cost based on data from 77 Chinese 3A hospitals in 2015. Front Oncol, 2022, 12: 857359.
108. Quinn TT, Miller GS, Rostek M, et al. Prosthetic breast reconstruction: indications and update. Gland Surg, 2016, 5(2): 174-186.
109. Agha-Mohammadi S, De La Cruz C, Hurwitz DJ. Breast reconstruction with alloplastic implants. J Surg Oncol, 2006, 94(6): 471-478.
110. Smith RW, Subramaniam S, Arora JS, et al. Cost effectiveness of prophylactic mastectomy and autologous flap reconstruction in BRCA1/2-positive patients. Plast Reconstr Surg, 2025, 156(4): 521-528.
111. Wu ZY, Han J, Kim HJ, et al. Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study. Breast Cancer Res Treat, 2022, 191(2): 365-373.
112. Algaithy ZK, Petit JY, Lohsiriwat V, et al. Nipple sparing mastectomy: can we predict the factors predisposing to necrosis? Eur J Surg Oncol, 2012, 38(2): 125-129.
113. De Vita R, Zoccali G, Buccheri EM, et al. Outcome evaluation after 2023 nipple-sparing mastectomies: our experience. Plast Reconstr Surg, 2017, 139(2): 335e-347e.
114. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci, 2004, 9: 283-289.
115. Kung TA, Kidwell KM, Speth KA, et al. Radiation-induced skin changes after postmastectomy radiation therapy: a pilot study on indicators for timing of delayed breast reconstruction. J Reconstr Microsurg, 2019, 35(3): 209-215.
116. Ho AY, Hu ZI, Mehrara BJ, et al. Radiotherapy in the setting of breast reconstruction: types, techniques, and timing. Lancet Oncol, 2017, 18(12): e742-e753.
117. Tanos G, Prousskaia E, Chow W, et al. Locally advanced breast cancer: autologous versus implant-based reconstruction. Plast Reconstr Surg Glob Open, 2016, 4(2): e622.
118. Franceschini G, Scardina L, Di Leone A, et al. Immediate prosthetic breast reconstruction after nipple-sparing mastectomy: traditional subpectoral technique versus direct-to-implant prepectoral reconstruction without acellular dermal matrix. J Pers Med, 2021, 11(2): 153.
119. Alderman A, Gutowski K, Ahuja A, et al. ASPS clinical practice guideline summary on breast reconstruction with expanders and implants. Plast Reconstr Surg, 2014, 134(4): 648e-655e.
120. Rizki H, Nkonde C, Ching RC, et al. Plastic surgical management of the contralateral breast in post-mastectomy breast reconstruction. Int J Surg, 2013, 11(9): 767-772.
121. Casella D, Fusario D, Cassetti D, et al. Controlateral symmetrisation in SRM for breast cancer: now or then? Immediate versus delayed symmetrisation in a two-stage breast reconstruction. Curr Oncol, 2022, 29(12): 9391-9400.
122. Lee KT, Mun GH. Prosthetic breast reconstruction in previously irradiated breasts: a meta-analysis. J Surg Oncol, 2015, 112(5): 468-475.
123. Tan S, Lim J, Yek J, et al. The deep inferior epigastric perforator and pedicled transverse rectus abdominis myocutaneous flap in breast reconstruction: a comparative study. Arch Plast Surg, 2013, 40(3): 187-191.
124. Tran BNN, Fadayomi A, Lin SJ, et al. Cost analysis of postmastectomy reconstruction: a comparison of two staged implant reconstruction using tissue expander and acellular dermal matrix with abdominal-based perforator free flaps. J Surg Oncol, 2017, 116(4): 439-447.
125. National Cancer Institute. SEER cancer statistics review, 1975-2021. National Cancer Institute, 2024.
126. Zhao J, Bian S, Di X, et al. A nomogram and risk classification system predicting the prognosis of patients with de novo metastatic breast cancer undergoing immediate breast reconstruction: a surveillance, epidemiology, and end results population-based study. Curr Oncol, 2023, 31(1): 115-131.
127. Weiss A, Chu CK, Lin H, et al. Reconstruction in the metastatic breast cancer patient: results from the national cancer database. Ann Surg Oncol, 2018, 25(11): 3125-3133.
128. Asaad M, Meaike J, Yonkus J, et al. Breast reconstruction in the setting of stage 4 breast cancer: is it worthwhile? Ann Surg Oncol, 2020, 27(12): 4730-4739.
129. Sue GR, Lee GK. Mastectomy skin necrosis after breast reconstruction: a comparative analysis between autologous reconstruction and implant-based reconstruction. Ann Plast Surg, 2018, 80(5S Suppl 5): S285-S287.
130. Jin R, Luo X, Wang X, et al. Complications and treatment strategy after breast augmentation by polyacrylamide hydrogel injection: summary of 10-year clinical experience. Aesthetic Plast Surg, 2018, 42(2): 402-409.
131. Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg, 2006, 118(3 Suppl): 7S-14S.
132. Chen L, Sha L, Huang SP, et al. Treatment for displacement of PAAG mixture after injection augmentation mammoplasty. Int J Clin Exp Med, 2015, 8(3): 3360-3367.
133. Ono S, Ogawa R, Hyakusoku H. Complications after polyacrylamide hydrogel injection for soft-tissue augmentation. Plast Reconstr Surg, 2010, 126(4): 1349-1357.
134. Shen H, Lv Y, Xu JH, et al. Complications after polyacrylamide hydrogel injection for facial soft-tissue augmentation in China: twenty-four cases and their surgical management. Plast Reconstr Surg, 2012, 130(2): 340e-348e.
135. Unukovych D, Khrapach V, Wickman M, et al. Polyacrylamide gel injections for breast augmentation: management of complications in 106 patients, a multicenter study. World J Surg, 2012, 36(4): 695-701.
136. Luo SK, Chen GP, Sun ZS, et al. Our strategy in complication management of augmentation mammaplasty with polyacrylamide hydrogel injection in 235 patients. J Plast Reconstr Aesthet Surg, 2011, 64(6): 731-737.
137. Xi TF, Fan CX, Feng XM, et al. Cytotoxicity and altered c-myc gene expression by medical polyacrylamide hydrogel. J Biomed Mater Res A, 2006, 78(2): 283-290.
138. 翟曉建, 倪鳴, 王征. 聚丙烯酰胺水凝膠注射隆乳后哺乳期乳腺感染的特點與治療. 中華醫院感染學雜志, 2014, 24(15): 3804-3806.Zhai XJ, Ni M, Wang Z. Characteristics and treatment of breast infection during lactation after augmentation mammoplasty with polyacrylamide hydrogel injection. Chin J Nosocomiol, 2014, 24(15): 3804-3806.
139. Cheng NX, Liu LG, Hui L, et al. Breast cancer following augmentation mammaplasty with polyacrylamide hydrogel (PAAG) injection. Aesthetic Plast Surg, 2009, 33(4): 563-569.
140. Xiao ZB, Liu Y. The relationship between breast cancer and breast augmentation with injected polyacrylamide gel: two case reports. J Plast Reconstr Aesthet Surg, 2008, 61(8): 981-982.
141. Godwin Y, Duncan RT, Feig C, et al. Soft, brown rupture: clinical signs and symptoms associated with ruptured PIP breast implants. Plast Reconstr Surg Glob Open, 2014, 2(11): e249.
142. Kim CH. Asian outcomes of primary breast augmentation in 162 consecutive cases by a single surgeon. Plast Reconstr Surg Glob Open, 2015, 3(10): e537.
143. Ding F, Zhao F, Jin R, et al. Management of complications in 257 cases of breast augmentation with polyacrylamide hydrogel, using two different strategies: a retrospective study. Aesthetic Plast Surg, 2022, 46(5): 2107-2121.
144. Qian B, Xiong L, Guo K, et al. Comprehensive management of breast augmentation with polyacrylamide hydrogel injection based on 15 years of experience: a report on 325 cases. Ann Transl Med, 2020, 8(7): 475.
145. Chen G, Wang Y, Huang JL. Breast cancer following polyacrylamide hydrogel injection for breast augmentation: a case report. Mol Clin Oncol, 2016, 4(3): 433-435.
146. 張晴, 謝妍妍, 梁法清, 等. 逆序腔鏡和傳統開放雙乳腺體切除聯合全胸肌后假體乳房重建術療效對比研究. 中國實用外科雜志, 2024, 44(11): 1263-1268.Zhang Q, Xie YY, Liang FQ, et al. Comparative analysis of efficacy of reverse sequence endoscopic and conventional open bilateral mastectomy with total subpectoral implant-based breast reconstruction. Chin J Pract Surg, 2024, 44(11): 1263-1268.
147. Yu L, Wang J, Zhang B, et al. Treatment of breast injection with polyacrylamide hydrogel with infiltrated fascia capsule removal: report on 104 cases. Aesthetic Plast Surg, 2012, 36(5): 1120-1127.
148. 鐘家媛, 楊煥佐, 謝妍妍, 等. 腔鏡奧美定取出聯合或不聯合即刻胸肌前假體植入隆胸療效比較. 中國修復重建外科雜志, 2024, 38(7): 807-812.Zhong JY, Yang HZ, Xie YY, et al. Effectiveness comparison of endoscopic removal of injectable Amazingel with/without immediate prepectoral implant-based breast augmentation. Chin J Repar Reconstr Surg, 2024, 38(7): 807-812.
149. 黃渭清, 王智, 宋可新, 等. 奧美定注射隆乳取出后二期假體隆乳術的療效觀察. 中國美容整形外科雜志, 2017, 28(7): 400-403.Huang WQ, Wang Z, Song KX, et al. Efficacy of second-stage breast augmentation after polyacrylamide hydrogel removal. Chin J Aesthet Plast Surg, 2017, 28(7): 400-403.
150. Panchal H, Matros E. Current trends in postmastectomy breast reconstruction. Plast Reconstr Surg, 2017, 140(5S): 7S-13S.
151. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med, 1997, 337(14): 949-955.
152. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med, 1997, 337(14): 956-962.
153. Moo TA, McMillan R, Lee M, et al. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Ann Surg Oncol, 2013, 20(10): 3169-3174.
154. EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 2014, 383(9935): 2127-2135.
155. Cordeiro PG, Albornoz CR, McCormick B, et al. The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: an analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years. Plast Reconstr Surg, 2014, 134(4): 588-595.
156. Lam TC, Borotkanics R, Hsieh F, et al. Immediate two-stage prosthetic breast reconstruction failure: radiation is not the only culprit. Plast Reconstr Surg, 2018, 141(6): 1315-1324.
157. Hvilsom GB, H?lmich LR, Steding-Jessen M, et al. Delayed breast implant reconstruction: is radiation therapy associated with capsular contracture or reoperations? Ann Plast Surg, 2012, 68(3): 246-252.
158. Ho AL, Bovill ES, Macadam SA, et al. Postmastectomy radiation therapy after immediate two-stage tissue expander/implant breast reconstruction: a University of British Columbia perspective. Plast Reconstr Surg, 2014, 134(1): 1e-10e.
159. Nava MB, Pennati AE, Lozza L, et al. Outcome of different timings of radiotherapy in implant-based breast reconstructions. Plast Reconstr Surg, 2011, 128(2): 353-359.
160. Cordeiro PG, Pusic AL, Disa JJ, et al. Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg, 2004, 113(3): 877-881.
161. Cordeiro PG, Albornoz CR, McCormick B, et al. What is the optimum timing of postmastectomy radiotherapy in two-stage prosthetic reconstruction: radiation to the tissue expander or permanent implant? Plast Reconstr Surg, 2015, 135(6): 1509-1517.
162. Kim M, Khavanin N, Jiang CZ, et al. Reconstructing failure: assessing surgical and patient-reported outcomes after loss of initial breast reconstruction. Plast Reconstr Surg, 2025, 155(4): 649e-659e.
163. Devalia HL, Mansfield L. Radiotherapy and wound healing. Int Wound J, 2008, 5(1): 40-44.
164. Serra-Mestre JM, Fernandez Pe?uela R, D’Andrea F, et al. Endoscopic delayed breast reconstruction with expanders and implants via the axillary incision made for sentinel lymph node biopsy or lymphadenectomy. Ann Plast Surg, 2018, 80(2): 100-103.
165. Zhang Q, Liang F, Li J, et al. Clinical outcomes and aesthetic results of reverse sequence endoscopic versus traditional bilateral nipple-sparing mastectomy with immediate implant-based breast reconstruction-an analysis of initial 116 patients from single institution. Front Oncol, 2025, 15: 1496592.
166. Chen D, Chen J, Huang Y, et al. Comparative analysis of surgical modalities for the gynecomastia treatment: efficiency and aesthetic outcomes. Andrology, 2024, 12(6): 1398-1407.
167. Rahmani S, Turton P, Shaaban A, et al. Overview of gynecomastia in the modern era and the Leeds Gynaecomastia Investigation algorithm. Breast J, 2011, 17(3): 246-255.
168. Koch T, Br?uner EV, Busch AS, et al. Marked increase in incident gynecomastia: a 20-year National registry study, 1998 to 2017. J Clin Endocrinol Metab, 2020, 105(10): dgaa440.
169. Cohen PG. The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt: a major factor in the genesis of morbid obesity. Med Hypotheses, 1999, 52(1): 49-51.
170. Liu C, Tong Y, Sun F, et al. Endoscope-assisted minimally invasive surgery for the treatment of glandular gynecomastia. Aesthetic Plast Surg, 2022, 46(6): 2655-2664.
171. Yao Y, Yang Y, Liu J, et al. Vacuum-assisted minimally invasive surgery: an innovative method for the operative treatment of gynecomastia. Surgery, 2019, 166(5): 934-939.
172. Diao X, Wang M, Chen D, et al. A comparative study on the short-term and long-term efficacy of endoscopic lipolysis, liposuction, and traditional open excision in gynecomastia treatment. BMC Endocr Disord, 2025, 25(1): 48.
173. Wang YC, Huang SH, Chen FM, et al. Effective minimally invasive strategy for mixed-type gynecomastia using vacuum-assisted mastectomy and power-assisted liposuction. J Plast Reconstr Aesthet Surg, 2024, 99: 175-184.
174. Tukenmez M, Emiroglu S, Kozanoglu E, et al. Single axillary incision endoscopic surgery and liposuction for gynecomastia. Medicine (Baltimore), 2023, 102(7): e33020.
175. Chengyu L, Jian Z, Xiaoxin J, et al. Experience of a large series of mastoscopic axillary lymph node dissection. J Surg Oncol, 2008, 98(2): 89-93.
176. Kühn T, Santjohanser C, Koretz K, et al. Axilloscopy and endoscopic sentinel node detection in breast cancer patients. Surg Endosc, 2000, 14(6): 573-577.
177. Liang Y, Xu S. Nonliposuction endoscopic sentinel lymph node biopsy through the periareolar incision. Surg Innov, 2020, 27(6): 570-579.
178. Hussein O, El-Nahhas W, El-Saed A, et al. Video-assisted axillary surgery for cancer: non-randomized comparison with conventional techniques. Breast, 2007, 16(5): 513-519.
179. Wang ZH, Gang TR, Wu SS, et al. Single-port endoscopic-sentinellymph node biopsy combined with indocyanine green and carbonnanoparticles in breast cancer. Surg Endosc, 2023, 37(10): 7591-7599.
180. Fang J, Ma L, Zhang YH, et al. Endoscopic sentinel lymph nodebiopsy and endoscopic axillary lymphadenectomy withoutliposuction in patients with early stage breast cancer. Surg Oncol, 2017, 26(4): 338-344.
181. Yao CC, Liu C, Xian J. Comparison of single-pore non-liposuction near-infrared laparoscopy with conventional open surgery for axillary sentinel lymph node biopsy in patients with early breast cancer: a single-center, small-sample retrospective study. World J Surg Oncol, 2023, 21(1): 66.
182. Ito K, Kanai T, Gomi K, et al. Endoscopic-assisted skin-sparing mastectomy combined with sentinel node biopsy. ANZ J Surg, 2008, 78(10): 894-898.
183. Yamashita K, Shimizu K. Endoscopic video-assisted breast surgery: procedures and short-term results. J Nippon Med Sch, 2006, 73(4): 193-202.
184. Mok CW, Lai HW. Endoscopic-assisted surgery in the management of breast cancer: 20 years review of trend, techniques and outcomes. Breast, 2019, 46: 144-156.
185. Tamaki Y, Sakita I, Miyoshi Y, et al. Transareolar endoscopy-assisted partial mastectomy: a preliminary report of six cases. Surg Laparosc Endosc Percutan Tech, 2001, 11(6): 356-362.
186. Lai HW, Chen ST, Liao CY, et al. Oncologic outcome of endoscopic assisted breast surgery compared with conventional approach in breast cancer: an analysis of 3426 primary operable breast cancer patients from single institute with and without propensity score matching. Ann Surg Oncol, 2021, 28(12): 7368-7380.
187. Lai HW, Mok CW, Chang YT, et al. Endoscopic assisted breast conserving surgery for breast cancer: clinical outcome, learning curve, and patient reported aesthetic results from preliminary 100 procedures. Eur J Surg Oncol, 2020, 46(8): 1446-1455.
188. Leff DR, Vashisht R, Yongue G, et al. Endoscopic breast surgery: where are we now and what might the future hold for video-assisted breast surgery? Breast Cancer Res Treat, 2011, 125(3): 607-625.
189. Sae-Lim C, Lai HW, Chennavasin P, et al. Single-port three-dimensional endoscopic-assisted axillary lymph node dissection (S-P 3D E-ALND): surgical technique and preliminary results. Breast J, 2024: 6319218.
190. Chen Y, Xu J, Liang Y, et al. A challenging therapeutic method for breast cancer: non-lipolytic endoscopic axillary surgery through periareolar incisions. Oncol Lett, 2020, 19(6): 4088-4092.
191. de Wilde RL, Schmidt EH, Hesseling M, et al. Comparison of classic and endoscopic lymphadenectomy for staging breast cancer. J Am Assoc Gynecol Laparosc, 2003, 10(1): 75-79.
192. Xiong H, Chen Z, Xu L, et al. Contrast of mastoscopic and conventional axillary lymph node dissection of patients with breast cancer: meta-analysis. Cancer Control, 2020, 27(2): 1073274820932987.
193. 張會強, 李健斌, 李曼, 等. 《CSCO乳腺癌診療指南2025》更新要點解讀. 中國腫瘤外科雜志, 2025, 17(3): 209-215.Zhang HQ, Li JB, Li M, et al. Interpretation of key updates in the 2025 Chinese Society of Clinical Oncology (CSCO) breast cancer diagnosis and treatment guidelines. Chin J Surg Oncol, 2025, 17(3): 209-215.
194. Lerman BJ, Popat RA, Assimes TL, et al. Association of left ventricular ejection fraction and symptoms with mortality after elective noncardiac surgery among patients with heart failure. JAMA, 2019, 321(6): 572-579.
195. 張思憶, 趙若寒, 婁杰, 等. 左心室功能第一階段射血分數的臨床研究進展. 臨床心血管病雜志, 2024, 40(11): 888-892.Zhang SY, Zhao RH, Lou J, et al. Clinical application progress of first phase ejection fraction. J Clin Cardiol, 2024, 40(11): 888-892.
196. Roy PM. Preoperative pulmonary evaluation for lung resection. J Anaesthesiol Clin Pharmacol, 2018, 34(3): 296-300.
197. Roungeris L, Devadze G, Talliou C, et al. Prediction of postoperative complications after major lung resection: a literature review. Anesth Res, 2024, 1(2): 146-156.
198. Licker MJ, Widikker I, Robert J, et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg, 2006, 81(5): 1830-1837.
199. 桂文萍, 崔宇航, 喬麗娟, 等. 改良 L 型肢體支撐架在腔鏡乳腺癌手術 "望月式" 體位中的應用. 護理學雜志, 2023, 38(10): 47-49.Gui WP, Cui YH, Qiao LJ, et al. Application of modified "L" type limb support in the "looking at the moon" position of endoscopic breast cancer surgery. J Nurs Sci, 2023, 38(10): 47-49.
200. 張霞, 王妙維, 李果, 等. 漸進式康復訓練對乳腺癌乳房重建患者上肢功能的影響. 中國康復, 2023, 38(12): 720-723.Zhang X, Wang MW, Li G, et al. Effects of progressive rehabilitation training on upper limb function of patients with breast cancer undergoing breast re-construction surgery . Chin J Rehabil, 2023, 38(12): 720-723.
201. She LC, Wang HY, Liu MF, et al. The relationship between self-perceived health and clinical symptoms in patients with frozen shoulders. Int J Environ Res Public Health, 2022, 19(21): 14396.
202. Wei TS. Endoscopy-assisted breast surgery for breast cancer. In: Mastering Endo-Laparoscopic and Thoracoscopic Surgery: ELSA Manual. Singapore: Springer, 2022: 169-173.
203. 中國醫師協會微無創分會乳腺專家委員會. 乳腺疾病腔鏡手術專家共識及操作指南(2021版). 中國微創外科雜志, 2021, 21(12): 1057-1067.Breast Expert Committee, Minimally Invasive and Non-invasive Branch of Chinese Medical Doctor Association. Expert consensus and operation guide for endoscopic surgery of breast diseases (2021 edition). Chin J Min Invasive Surg, 2021, 21(12): 1057-1067.
204. Kusunose M, Inui A, Nishimoto H, et al. Measurement of shoulder abduction angle with posture estimation artificial intelligence model. Sensors (Basel), 2023, 23(14): 6445.
205. 顧麗英, 馮靜英. 團體健康教育對乳腺癌術后患肢功能鍛煉的效果觀察. 上海預防醫學, 2016, 28(8): 585-587.Gu LY, Feng JY. Observation of the effect of group health education on functional exercise of affected limbs after breast cancer surgery. Shanghai J Prev Med, 2016, 28(8): 585-587.
206. 陳允允, 張男, 董曉晶, 等. 專科護士主導的團隊合作模式促進乳腺癌患者上肢功能康復. 護理學雜志, 2022, 35(17): 75-79.Chen YY, Zhang N, Dong XJ, et al. The effect of specialized nurse-led teamwork model in the recovery of upper-limb motor function in breast cancer patients. J Nurs Sci, 2022, 35(17): 75-79.
207. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer (version 2.2025). 2025.
208. Urban C, Rietjens M, El-Tamer M, et al. Oncoplastic and Reconstructive Breast Surgery (second edition). Cham: Springer, 2019.
209. 陳莉明, 陳偉, 陳燕燕, 等. 成人圍手術期血糖監測專家共識. 中國糖尿病雜志, 2021, 29(2): 81-85.Chen LM, Chen W, Chen YY, et al. Expert consensus on perioperative blood glucose monitoring in adults. Chin J Diabetes, 2021, 29(2): 81-85.
210. White L. Peri-operative management of the surgical patient with diabetes: a guideline summary. 2016.
211. Membership of the Working Party, Barker P, Creasey PE, et al. Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia, 2015, 70(12): 1427-1440.
212. Hart A, Funderburk CD, Chu CK, et al. The impact of diabetes mellitus on wound healing in breast reconstruction. Ann Plast Surg, 2017, 78(3): 260-263.
213. Liu Q, Aggarwal A, Wu M, et al. Impact of diabetes on outcomes in breast reconstruction: a systematic review and meta-analysis. J Plast Reconstr Aesthet Surg, 2022, 75(6): 1793-1804.
214. Zucker I, Bouz A, Castro G, et al. Smoking as a risk factor for surgical site complications in implant-based breast surgery. Cureus, 2021, 13(10): e18876.
215. Prantl L, Moellhoff N, Fritschen UV, et al. Impact of smoking status in free deep inferior epigastric artery perforator flap breast reconstruction: a multicenter study. J Reconstr Microsurg, 2020, 36(9): 694-702.
216. Chang DW, Reece GP, Wang B, et al. Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg, 2000, 105(7): 2374-2380.
217. Park HS, Lee J, Lai HW, et al. Surgical and oncologic outcomes of robotic and conventional nipple-sparing mastectomy with immediate reconstruction: international multicenter pooled data analysis. Ann Surg Oncol, 2022, 29(11): 6646-6657.
218. He X, Hou L, Wang D, et al. Clinical application of endoscopic radical mastectomy for breast cancer combined with total pectoral muscle reconstruction with breast implants. Chin J Repar Reconstr Surg, 2024, 38(7): 786-792.
219. Wan A, Liang Y, Chen L, et al. Association of long-term oncologic prognosis with minimal access breast surgery vs conventional breast surgery. JAMA Surg, 2022, 157(12): e224711.
220. Xu X, Gao X, Pan C, et al. Postoperative outcomes of minimally invasive versus conventional nipple-sparing mastectomy with prosthesis breast reconstruction in breast cancer: a meta-analysis. J Robot Surg, 2024, 18(1): 274.
221. Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med, 1990, 322(3): 153-160.
222. Bold RJ, Mansfield PF, Berger DH, et al. Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. Am J Surg, 1998, 176(3): 239-243.
223. Gulluoglu BM, Guler SA, Ugurlu MU, et al. Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients: a randomized controlled trial. Ann Surg, 2013, 257(1): 37-43.
224. Phillips BT, Fourman MS, Bishawi M, et al. Are prophylactic postoperative antibiotics necessary for immediate breast reconstruction? Results of a prospective randomized clinical trial. J Am Coll Surg, 2016, 222(6): 1116-1124.
225. Gahm J, Ljung Konstantinidou A, Lagergren J, et al. Effectiveness of single vs multiple doses of prophylactic intravenous antibiotics in implant-based breast reconstruction: a randomized clinical trial. JAMA Netw Open, 2022, 5(9): e2231583.
226. Hinson C, Sink M, Sammer D, et al. Extended antibiotic prophylaxis in implant-based breast reconstruction: a systematic review and meta-analysis. Aesthet Surg J, 2025, 45(11): 1152-1158.
227. In SK, Park SW, Myung Y. Effect of perioperative prophylactic intravenous antibiotic use in immediate implant-based breast reconstruction: a retrospective matched cohort study. Arch Plast Surg, 2024, 51(1): 36-41.
228. Du X, Duan X, Zhou X, et al. A study on the correlation between MRI-assessed breast volume asymmetry and patient satisfaction after immediate breast reconstruction in breast cancer patients. Sci Rep, 2024, 14(1): 30737.
229. Bassetto F, Pandis L, Facchin F, et al. Braxon?-assisted prepectoral breast reconstruction: a decade later. Front Surg, 2022, 9: 1009356.
230. Taj S, Chandavarkar R, Vidya R. Current global trends in prepectoral breast reconstruction. Medicina (Kaunas), 2024, 60(3): 431.
231. Liu LQ, Branford OA, Mehigan S. BREAST-Q measurement of the patient perspective in oncoplastic breast surgery: a systematic review. Plast Reconstr Surg Glob Open, 2018, 6(8): e1904.
232. Baek WY, Byun IH, Kim YS, et al. Patient satisfaction with implant based breast reconstruction associated with implant volume and mastectomy specimen weight ratio. J Breast Cancer, 2017, 20(1): 98-103.
233. Ma JX, Xia YC, Li B, et al. Unilateral tissue expander/implant two-stage breast reconstruction with the assistance of three-dimensional surface imaging. Aesthetic Plast Surg, 2020, 44(1): 60-69.
234. 馬建勛, 夏有辰, 李比. 乳房再造術中的假體選擇策略. 組織工程與重建外科, 2023, 19(2): 152-156.Ma JX, Xia YC, Li B. Prosthesis selection strategy in breast reconstruction. J Tissue Eng Reconstr Surg, 2023, 19(2): 152-156.
235. Dai H, Cao X, Wu H, et al. Reverse-sequence endoscopic nipple-sparing mastectomy with direct-to-implant breast reconstruction and air inflation adjustment technique in patients with large or severely ptotic breast: a single-center prospective cohort study. Int J Surg, 2025, 111(6): 3838-3849.
236. Qiu J, Wen N, Xie Y, et al. Novel technique for endoscopic-assisted nipple-sparing mastectomy and immediate breast reconstruction with endoscopic-assisted latissimus dorsi muscle flap harvest through a single axillary incision: a retrospective cohort study of comparing endoscopic and open surgery. Gland Surg, 2022, 11(8): 1383-1394.
237. 駱成玉, 劉寶胤. 乳腔鏡男子乳腺發育微創手術專家共識及操作指南 (2019 版). 中國微創外科雜志, 2019, 19(11): 961-963.Luo CY, Liu BY. Expert consensus and operation guide for minimally invasive endoscopic surgery for gynecomastia (2019 edition). Chin J Min Invasive Surg, 2019, 19(11): 961-963.
238. 中國抗癌協會乳腺癌專業委員會, 中國醫師協會外科醫師分會, 上海市抗癌協會乳腺癌專業委員會. 乳腺腫瘤整形與乳房重建專家共識 (2022年版). 中國癌癥雜志, 2022, 32(9): 836-892.China Anti-Cancer Association, the Society of Breast Cancer; Breast Surgeons Committee of Surgeons Branch, Chinese Medical Doctor Association; Committee of Breast Cancer Society, Shanghai Anti-Cancer Association. Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition). China Oncol, 2022, 32(9): 836-892.
239. 王子函, 毛開源, 謝菲. 腔鏡胸肌前假體乳房重建術技術要點. 中國實用外科雜志, 2024, 44(11): 1215-1219.Wang ZH, Mao KY, Xie F. Technical key points of endoscopic prepectoral breast reconstruction with implants. Chin J Pract Surg, 2024, 44(11): 1215-1219.
240. 唐鵬, 何佳玲. 《乳腺腫瘤整形與乳房重建專家共識 (2022年版) 》腔鏡手術部分解讀. 中國實用外科雜志, 2024, 44(11): 1243-1245.Tang P, He JL. Interpretation of expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition). Chin J Pract Surg, 2024, 44(11): 1243-1245.
241. Dua MM, Bertoni DM, Nguyen D, et al. Using intraoperative laser angiography to safeguard nipple perfusion in nipple-sparing mastectomies. Gland Surg, 2015, 4(6): 497-505.
242. Pruimboom T, Schols RM, Van Kuijk SM, et al. Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction. Cochrane Database Syst Rev, 2020, 4(4): CD013280.
243. Elmelegy N, Shokr T, Osama M. Nipple-areola complex ischemia or necrosis in freestyle perforator flap reduction mammoplasty operations. Aesthetic Plast Surg, 2019, 43(6): 1506-1514.
244. Zhou J, Liu X, Feng Y, et al. Breakthrough in breast reconstruction in the context of COVID-19: safety and efficiency of endoscopic breast reconstruction at a day surgery center. Gland Surg, 2021, 10(8): 2477-2489.
245. Lai HW, Chen ST, Mok CW, et al. Single-port three-dimensional (3D) videoscope-assisted endoscopic nipple-sparing mastectomy in the management of breast cancer: technique, clinical outcomes, medical cost, learning curve, and patient-reported aesthetic results from 80 preliminary procedures. Ann Surg Oncol, 2021, 28(12): 7331-7344.
246. Lai HW, Lin SL, Chen ST, et al. Single-axillary-incision endoscopic-assisted hybrid technique for nipple-sparing mastectomy: technique, preliminary results, and patient-reported cosmetic outcome from preliminary 50 procedures. Ann Surg Oncol, 2018, 25(5): 1340-1349.
247. Zhang S, Xie Y, Liang F, et al. Video-assisted transaxillary nipple-sparing mastectomy and immediate implant-based breast reconstruction: a novel and promising method. Aesthetic Plast Surg, 2022, 46(1): 91-98.
248. 中國抗癌協會腫瘤整形外科專業委員會, 中國抗癌協會腫瘤麻醉與鎮痛專業委員會. 乳房再造加速康復外科中國專家共識 (2022版). 中國腫瘤臨床, 2023, 50(8): 379-384.Committee of Oncoplastic Surgery, Chinese Anti-Cancer Association; Committee of Oncologic Anesthesia and Analgesia, Chinese Anti-Cancer Association. Chinese expert consensus on enhanced recovery after surgery in breast reconstruction (2022 edition). Chin J Clin Oncol, 2023, 50(8): 379-384.
249. Alabaster K, Homsy C, Puyana S, et al. Exercise after breast reconstruction surgery: evaluating current trends and practices of U. S. plastic surgeons. Plast Reconstr Surg Glob Open, 2021, 9(10): e3857.
250. De Groef A, Van Kampen M, Dieltjens E, et al. Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil, 2015, 96(6): 1140-1153.
251. Bruce J, Mazuquin B, Mistry P, et al. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT. Health Technol Assess, 2022, 26(15): 1-124.
252. Chua C, Bascone CM, Pereira C, et al. Final 24-hour drain output and postoperative day are poor indicators for appropriate drain removal. Plast Reconstr Surg Glob Open, 2022, 10(4): e4160.
253. Chen CF, Lin SF, Hung CF, et al. Risk of infection is associated more with drain duration than daily drainage volume in prosthesis-based breast reconstruction: a cohort study. Medicine (Baltimore), 2016, 95(49): e5605.
254. Lembo F, Cecchino LR, Parisi D, et al. Reduction of seroma and improvement of quality of life after early drain removal in immediate breast reconstruction with tissue expander. Preliminary report from a randomized controlled study. J Plast Reconstr Aesthet Surg, 2021, 74(10): 2565-2572.
255. Gadiraju GK, Prospero MR, Tobias F, et al. Understanding the impacts of surgical drains on postoperative pain and quality of life. Plast Reconstr Surg Glob Open, 2025, 13(1): e6474.
256. Sobti N, Weitzman RE, Nealon KP, et al. Evaluation of capsular contracture following immediate prepectoral versus subpectoral direct-to-implant breast reconstruction. Sci Rep, 2020, 10(1): 1137.
257. Yang H, Liang F, Xie Y, et al. Single axillary incision reverse-order endoscopic nipple/skin-sparing mastectomy followed by subpectoral implant-based breast reconstruction: technique, clinical outcomes, and aesthetic results from 88 preliminary procedures. Surgery, 2023, 174(3): 464-472.
258. Shammas RL, Levy J, Boe LA, et al. Risk of radiation-induced capsular contracture following subpectoral or prepectoral implant-based breast reconstruction. Plast Reconstr Surg, 2026, 157(1): 6e-14e.
259. Sewart E, Turner NL, Conroy EJ, et al. The impact of radiotherapy on patient-reported outcomes of immediate implant-based breast reconstruction with and without mesh. Ann Surg, 2022, 275(5): 992-1001.
260. Seth AK, Cordeiro PG. Stability of long-term outcomes in implant-based breast reconstruction: an evaluation of 12-year surgeon- and patient-reported outcomes in 3489 nonirradiated and irradiated implants. Plast Reconstr Surg, 2020, 146(3): 474-484.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Guidelines for endoscopic and robotic breast surgery in China (2026 edition): Part two

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content